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Abstract  
 
1. The thesis describes the synthesis of new compounds including 
both N- and 0-acyl sphingoids, N- and 0-acyl p.-hydroxyaminoacids, 
related oxazolines, and aminoacid esters and amides of lipids. 
2. Some minor lipids chromatographed with ceramides from commercial 
and fresh biological sources were identified as partially oxidised 
cerebrosides and monoglycerides respectively. 
3. Chromatographic methods (TLC and GLC) were elaborated for the 
study of sphingolipids with special reference to the study of 
a) acyl migration; 
b) ageing; 
c) stereochemistry. 
4. Resolution of groups of erythro and threo sphingoids by TLC and 
separation of individual diastereoisomers by GLC permitted the 
assignment of erythro configuration to natural sphingoids of brain. 
5. It was shown that synthetic oxazolines derived from sphingoids and 
containing 0
1 
and 0
3 
in the ring were predominantly of the former 
kind if derived from erythro sphingoids, and of the latter kind if 
derived from threo sphingoids. 
6. All oxazolines, except those derived from erythro sphingenine and 
containing 03 in the ring, underwent acid hydrolysis without change  
of configuration. 
7. Synthetic 0-acyl sphingoids readily changed to ceramides in neutral 
or alkaline media but the conversion of ceramides to 0-acyl isomers 
could not be brought about by acid; oxazoline intermediates were 
not found. 
8. Neither oxazolines nor 0-acyl sphingoids have been found in fresh or 
aged ceramide solutions. Changes of ceramides on ageing are 
ascribed to photo-oxidation. 
9. The fatty acid composition of sphingolipids from the milk of Friesian 
cows was surveyed. 
10. The neutral lipids of 68 workers exposed to lead were assayed. 
	
11. 	Studies of aminoacids in neutral lipid fractions suggest the presence 
of some covalently bound aminoacid-lipid combinations. 
(i v) 
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INTRODUCTION  
1. Definition  
This work is a report of analytical, synthetic, and mechanistic 
studies of ceramides and some of their constitutional or chromatographic 
analogues. 
2. Nomenclature, abbreviations, symbols and other conventions  
(a) Nomenclature  
The recently revised nomenclature for sphingolipids , will be 
adopted where possible. 
The term "sphingoids" will refer to 2-amino-1,3-octadecanediol, 
its homologues and stereoisomers, and to the hydroxy, methoxy, and 
unsaturated derivatives of these compounds. "Sphingenines" and 
"sphinganines" denote the stereoisomers of 2-amino-trans-4-octadecene-
1,3-diol and 2-amino-1,3-octadecanediol, respectively. 
The configuration of substituents on sphingoids or 2-hydroxy 
fatty acids is specified where necessary by the prefixes "D" or "L" 
(not "R" or "S") which follow the locant of substitution. These 
prefixes specify the orientation of the functional groups to the right 
or left, respectively, of the carbon chain when written vertically in 
a Fischer projection with Cl at the top. The notations "e" (erythro) 
or "t" (threo) are used when two adjacent substituents have the same 
or opposite configuration, respectively. The term "rac" (racemic) 
represents a mixture of the DLe and DLt-stereoisomers. Examples of 
sphingoids differing in configuration are given (Fig. 1). 
CH 2 OH 
HERal4 ---2, NH 2 
--1-140H 
1 
(CH 2 ) 14 
3 
CH 2  OH 1  
H2Ncmft-6-.asH 
Hem.1..ma0H 
1 
(CH2 ) 14 
3 
2D,3D-sphinganine, or 21.,3D-sphinganine, or 
De-sphinganine •Dt-sphinganine 
cH 9OH 
' 
H 	--ma NH 2 
Flea:0"`C-m3001-1 
Hosow-C-.010H 
(61 2 ) 13 
3 
4D-hydroxy-De-
sphinganine 
Fig. 1  
H 2 C e)C—(CH 2 ) 12CH 3 
OH 
C—H 
(H
2 ) 12 
Li
3 
2-tridecy1-4-(1D-hydroxy-trans-2-hexadeceny1)-2-oxazoline 
Fig. 2 
The terms "ceramide" and "N-acyl sphingoid" are equivalent. 
The generic terms, sphingolipids, ceramides, sphingomyelins, 
and glycosphingolipids, will be used. The last-mentioned lipids 
include all compounds containing at least one monosaccharide, such as 
glucosylceramides (or generally, cerebrosides), lactosylceramides, 
psychosines, sulphatides, and gangliosides. The configuration of 
the sphingoids in these groups of compounds, generally believed to be 
De, will be specified where known, e.g. DLt-sphingomyelin. 
Acyl sphingoids include N-acyl, 0-acyl (e.g. 3-0-palmitoyl 
sphingenine), and di- or tri-acyl compounds in which the locations of 
the acyl groups are indicated so as to distinguish 1-0,3-0, 1-0,N, 
and 3-0,N derivatives. The term "ceramide esters" implies that one 
of the hydroxyls of ceramides is esterified, as in the known cerebroside 
esters of brain. 
2-Oxazolines derived from sphingoids shall be termed "sphingoid-
oxazolines". The oxygen not participating in the ring is indicated 
a 
as a hydronpane or hydroxyalkene substituent, e.g. 2-tridecy1-4- 
(1D-hydroxy-trans-2-hexadeceny1)-2-oxazoline (Fig. 2). 
(b) Abbreviations  
In addition to the common abbreviations such as Me (methyl) and 
Trid (tridecyl), others will be used, e.g. lh-Hexad A2 , for 1-hydroxy-
trans-2-hexadecenyl. 
hMe, for hydroxymethyl. 
cEy, for carboethoxy. 
TLC and GLC stand for thin-layer chromatography and gas-liquid 
chromatography, respectively. 
JR. UV, NMR, and MS spectra refer to infrared, ultraviolet, 
nuclear magnetic resonance, and mass spectroscopy, respectively. 
4 
Trimethylsilyl and dinitrophenyl are abbreviated as TMSi and DNP, 
respectively. 
NFA, for non-hydroxy fatty acid, and HFA, for 2-hydroxy fatty 
acid, will be used for the classification of sphingolipids. 
(c) Symbols  
Non-hydroxy fatty acids (or methyl esters) are symbolised by 
carbon number:number and position of double bonds; the double bond 
has the cis arrangement unless otherwise indicated. Thus, 18:1(9) 
stands for oleic acid. In the case of 2-hydroxy fatty acids, the 
configuration of the hydroxy group is specified, and the letter h 
precedes the symbols. Thus, D-h18:0 stands for D-2-hydroxystearic 
acid. 
Sphingoids are symbolised by carbon number:number of double 
bonds, but distinguished from fatty acids with the letters d or t, 
which stand for dihydroxy and trihydroxy respectively (i.e. the 
number of hydroxy groups in the sphingoid). The ones most encountered 
are d18:1 (sphingenines), d18:0 (sphinganines), and t18:0 (4D-hydroxy-
De-sphinganine); the double bond of d18:1 occurs at C4, and has the 
trans-configuration unless otherwise stated. 
The notations used for acyl sphingoids are combinations of the 
symbols described for fatty acids and sphingoids, e.g. D-h18:0-Dt-
d18:1 (a ceramide), and 3-0-18:0-0t-d18:1 (an 0-acyl sphingoid). 
(d) Other conventions  
Melting points are shown as °, which refers to °C. 
IR spectral frequencies are given in cm
-1 
(wavenumbers); 
stretching and bending modes are indicated by the symbols v and 6, 
respectively. 
5 
NMR spectral data are given in T values. 
3. Nature and scope of investigations  
Earlier work in this Department
2 
drew attention to problems 
associated with the TLC analysis of ceramides. 
The identification and estimation of ceramides by means of TLC 
is rendered difficult or critically unacceptable through the presence 
of other lipids of comparable mobility. The main contaminants were 
identified as cholesterol, fatty acids, and a-monoglycerides. Simple 
techniques sufficed to separate them from ceramides. 
Gradual loss of homogeneity in purified ceramide preparations 
indicates chemical change. The identification of the reaction 
products, and the establishment of the mode of their formation from 
parent ceramides, constitutes a substantial part of the work presented 
in this thesis. The most likely products arising in ageing ceramide 
solutions were the 3-0-acyl sphingoids, which could be derived from 
ceramides by acyl migration through oxazoline (or oxazolidine) 
intermediates (Fig. 3). 
Other products of interest were anhydrides, e.g. tetrahydropyrans 
(Fig. 4), which could form via an epoxide 3 , and 1,4-tetrahydrooxazines 
(Fig. 5), which may arise from HFA ceramides. 
Model ipounds of acylated sphingoids and sphingoid-oxazolines 
were prepared, and their chemistry studied with their presence in 
natural products in view. The presence of at least two asymmetric 
centres gave rise to problems of distinguishing between stereoisomers. 
Related model compounds derived from -hydroxy amino acids were also 
prepared and used to study acyl migrations and stereochemical 
conditions. 
1-0-acyl sphingoids 
6 
H 	H 	 H 	H 	 H 	H 
I 
	
R C — C --- CH 	R C—C---- CH 	R — C — C — CH 2 2 
1 	I 	1 	2 IOH 	INH 	6H H IN
\/
10 OH NH 0 
2 1 s  
C= 0 C= 0 
-? 
11/ 
I 	I  
H 	H 
R C — C --- CH 	 ——CH 	 — CH , 2 I 	2•—OH H 	 1 2 OH 	0 	NFLOH \\, 
-OH 
IIV 	 lit' 
cerami des oxazolines 	3-0-acyl sphingoids 
Fig. 3 
1 1 
H2OH 
R 	NH 
tetrahydropyrans 	1,4-tetrahydrooxazines 
Fig. 4 Fig. 5  
Legend  
R,R', and R" are long-chain alkyl groups. 
7 
Some minor problems were met with in connection with the TLC 
analysis of ceramides. 
(i) The finding of amino acids in lipids of comparable mobility to 
ceramides suggested the presence of lipoamino acids, which might 
have been derived from glycerol, fatty acids, cholesterol or 
sphingoids. 
(ii) In some commercial ceramide preparations anomalous TLC spots, 
slower than the parent ceramides, were detected. These were shown 
to be due to polyols formed in the course of preparation of the 
ceramides. 
(iii) Ceramides and other lipids exposed to subdued sunlight for 
relatively short periods of time underwent photooxidation, giving 
rise to anomalous TLC spots. 
4. , Structure of the thesis  
Work submitted in the form of this thesis is divided as follows: 
CHAPTER 1. Materials, methods for their isolation, and 
some qualitative and quantitative analytical procedures. 
CHAPTER 2. The analysis of major contaminants in natural 
and commercial ceramide preparations. Evidence for new naturally 
occurring minor lipids derived from sphingoids. The synthesis and 
chemical nature of acyl sphingoids, sphingoid-oxazolines, and related 
compounds. 
CHAPTER 3. The stereochemical analysis of acyl sphingoids 
and sphingoid-oxazolines. 
Some of the methods and findings of Chapters 1 to 3 have found 
application in short projects reported in the Appendices. 
8 
APPENDIX 1. A survey of sphingolipids in the milk of 
Friesian cows. 
APPENDIX 2. A survey of serum lipids in workers exposed 
to lead. 
APPENDIX 3. Lipoamino acids. 
5. Review  
(a) Controversies relating to the existence of natural threo-
sphingolipids  
The major sphingoids isolated from tissues are De-d18:1 and 
De-d18:0, from animals4-7 , and t18:0, from plants 8 . The biosynthesis 
of sphingolipids requires e-sphingoids, but their diastereoisomers can 
play an equally active part. All isomers have been found to accept 
the acyl group to form ceramides enzymatically in vitro 9 and in vivo l° . 
Psychosine may be prepared from a variety of e- and t-sphingoids, 
especially the former
11
. 
In the biosynthetic pathways leading to sphingomyelin, several 
authors were sceptical of the role of t-d18:1 as an active lipid 
acceptor. The N-acylation of sphingenyl-l-phosphorylcholine in rat 
brain gave a product which showed the chromatographic properties of 
t-sphingomyelins
12
. This finding was questioned, since the 
sphingenine synthesised in rat brain was known to have the 
e-configurat'qn 6 . Some thought that the sphingenyl-l-phosphoryl- 
choline isomerised during its preparation 13 , while others noted 
discrepancies in its analytical data
14
. Recent claims that sphingenyl- 
or sphinganyl-l-phosphorylcholine function neither as intermediates 
in the biosynthesis nor in the degradation of sphingomyelin have only 
added to confusion15. 
9 
Evidence for natural t-sphingolipids was also obtained from 
investigations on the biosynthesis of sphingomyelin from CDP-choline 
and ceramides
16
. Using an enzyme system from chicken liver, 
t-ceramides were the only active substrates, even though sphingoids 
from chicken liver have the e-configuration. More recently, another 
enzyme (cholinephosphotransferase) has been found to catalyse the 
reaction using either t- or e-ceramides
14
. 
(b) Acyl migrations in systems related to ceramides  
The mechanism and stereochemical course of acyl migrations 
between nitrogen and oxygen atoms on adjacent carbons have been 
critically investigated; in many cases oxazoline intermediates 
were prepared
17-23
. The most important results of such investigations 
are summarised in Fig. 6. In general, dry hydrogen chloride at room 
temperature converts cis-acylaminoalcohols (II) to esters (III) with 
retention of configuration; (III) reverts to (II) on treatment with 
alkali. The trans-acylaminoalcohols (I) are unaffected by this mild 
treatment, but heating with hydrogen chloride brings about acyl 
migration accompanied by an inversion of configuration, and ester (III) 
is formed. 
Retention and inversion mechanisms have been postulated to 
explain configurational changes that occur during treatment of 
acylaminoalcohols with acid (Fig. 7)
17
. The possibility of inversion 
prior to acyl migration has also been considered 19 . The mechanisms are 
thought to involve transient cyclic hemiacetals (V) rather than oxazolines 
(VI) (Fig. 8). The 0 to N migration in N-(2-hydroxyethyl)-benzamide  did 
not yield an oxazoline intermediate, but in the N to 0 migration, some 2- 
phenyloxazoline was isolated
24
. This suggests that in similar systems, 
OH 	H 
H 	NH 
0=C 
10 
H 	H 
SOC1 2 	V 	+NI/H]C 	SOC1 2  l - inversion 	0' \ , 	( retention C 
I 	
IV 
R  
II 
H 0 - 2 
refention 
mild 11 -1. retention 
HCI, A inversion 
III 
R — CH — CH — R1 
	
1 	, 1 
HO 	NH 
\NI
/ 
R 	-  
Fig. 6 
R --- CH — CH — R1 1 	1 
HO
+ NH 
\
/ 
R/ \OH 2  
R -- CH — CH — R i 
1 	1 
0 	NH
+ 
1 	3 
R2 	0 
. 	Retention mechanism 
H---)0H 
1 
R -- CH -- CH 	R 1 
0 	NH 	-H20 
R2 	2  
R --- CH --- CH --- R 1 R — CH --- CH --- R 1 1 	1 1 	1 
0 	NH 	 0 	NH 3 
/C 
R2 	OH 2 	 2 	.0 
B. 	Inversion mechanism 
Fig. 7 
1 1 
r 	r 0 NH 
\
c
/ 
Y- 
R 
/OH 
V I 
fig. 8  
oxazolines may be formed during migrations. 
The migration of the acyl group in ceramides to either the Cl-
or the C3-hydroxyl, via oxazolines or oxazolidines, is a possibility 
which has not been investigated. Past work has suggested that 
during acid hydrolysis of natural sphingolipids, some acyl migration 
to the C3-hydroxyl occurs via 2-hydroxy oxazolidine intermediates 
(cf. V, Fig. 8)
25,26
. Inversion at C3 during acid hydrolysis is 
known to occur since t-sphingoids may be isolated
27,28
. The migration 
is thought to proceed through the inversion mechanism (Fig. 7), which 
has more recently been verified 18 . In sphingolipids, there are two 
hydroxy groups to which the acyl group may migrate; also the C3- 
migration may be affected by either the allylic double bond or the 
long-chain alkyl group of the sphingoid. As yet, 0-acyl sphingoids 
have not been prepared. Oxazolines
25,29 
:nd oxazolidines
30 , derived 
from De-d18:0 or De-18:1, and containing a phenyl group in the 2- _ 
position on the ring, have been successfully prepared. 
An acyl migration of a different nature was noticed during the 
attempted dephosphorylation of sphingomyelin with acetic acid-acetic 
31. anhydride , similar migrations were observed in glycerophosphatides
32
. 
12 
This type of migration was thought to be a carbon-to-carbon acetoxyl 
shift rather than a nitrogen-to-oxygen acyl shift 31 . 
Anhydrides (e.g. Figs. 4,5) derived from N-acyl dihydroxy 
sphingoids have not been studied so far as is known. However, in 
plant materials, tetrahydrofuran derivatives have been produced from 
phytosphingolipids by dehydration in acid 33 ' 34 ; more recently, natural 
anhydrocerebrins have been found35. 
13 
CHAPTER 1  
MATERIALS AND METHODS 
1. Materials and equipment  
(a) Lipids  
The main suppliers of materials are abbreviated, KL, APS, SIG, 
and F for Koch-Light Laboratories, Ltd., Applied Science Laboratories, 
Inc., Sigma Chemical Co., and Fluka AG,-Chemische Fabrik, respectively. 
Others less frequently referred to will be mentioned at the 
appropriate places. 
Lipids from commercial sources are listed (Table 1). 
Stereoisomers of sphingenine DLe, and DLt-isomers) were 
prepared from brain sphingolipids. 
Pure DLt-sphinganine was prepared from the commercially available 
compound, which contained some e-sphinganine as an impurity. 
Glucosylceramideand lactosylceramide were obtained from milk 
sphingolipids. 
Synthetic ceramides were prepared as described by others
36
. 
(b) Other chemicals  
Amino acids of greater than 99% purity were obtained from SIG. 
N-ethyl-N'-dimethylaminopropyl carbodiimide was obtained from 
Serva Biochemicals Inc., 1-fluoro-2,4-dinitrobenzene from KL, and 
aliphatic nitriles from Aldrich Chemical Co., Inc.. 
The reagents for silylation, bis(trimethylsilyl)trifluoro- 
acetamide, trimethylchlorosilane and SIL-PREP were supplied by APS. 
14 
Tablel. Commercial preparations  
1. Ceramides, from bovine brain cerebrosides (KL) 
2. NFA ceramides, from brain cerebrosides (APS,SIG) 
3. HER ceramides, from brain cerebrosides (APS,SIG) 
4. Ceramides, from bovine brain sphingomyelin (SIG) 
5. Ceramides, natural mixture (APS) -- 
6. N-palmitoyl or N-lignoceroyl sphinganine (Miles-Yeda, Ltd.) 
7. Cerebrosides, from bovine brain, highly purified (KL) 
8. Cerasine (N-1ignoceroy1 :DL-sphingeny1-f3-D-ga1actoside) (SIG) 
9. Sphinganine, rac synthetic (KL) 
10. Sphinganine, e or t synthetic (SIG) 
11. 4D-hydroxy-De-sphinganine, from yeast (SIG) 
12. Sphingenine sulphate, from bovine brain sphingolipids (KL) 
13. Sphingomyelin, from bovine brain (KL,SIG) 
14. Cephalin, natural (egg yolk) or L -a- and DL-a-synthetic (F) 
15. Lecithin, L -a- and DL-a-synthetic (F) 
16. Phosphatidyl ethanolamine, syntheti: (KL) 
17. Phosphatidyl-L-serine, from bovine brain, pure CHR (KL) 
18. Lysolecithin (KL) • 
19. Cholesterol and cholesterol esters (F) 
20. Glycerides, synthetic (SIG,APS) 
21. Fatty acids and methyl esters, non-hydroxy type (SIG) 
22. Methyl esters, branched chain (APS) 
23. Methyl esters, 2-hydroxy type (APS) 
24. Fatty acids, 2-hydroxy type (F, Serva Biochemicals Inc.). 
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(c) Chromatographic materials and equipment  
Silica gel G (and GF254 ) and commercially prepared plates were 
supplied by E. Merck. 
• Silicic acids for column chromatography were supplied by SIG 
(SIL-LC type) and Mallinckrodt Chemical Works (100-120 mesh powder). 
Gas Chrom Q and liquid phases (GE SE-30 (GC grade), OV-1, OV-7, 
OV-17, and EGSS-X) were obtained from APS. 
TLC tanks were supplied by Camag Inc., and the plate spreader by 
Shandon Southern. 
(d) Instruments  
The GLC analysis of methyl esters was carried out on a Phillips 
PV4000 gas chromatograph, while sphingoids, ceramides, and amino acids 
were analysed on a Shimadzu GC-4BMPFE instrument; detection in both 
cases was by means of flame ionisation. 
A Hilger-Watts spectrodensitometer was modified by Mr. A. Bottomley, 
Research Officer, University of Tasmania, for the scanning of TLC plates. 
Photography was done with a Polaroid overhead camera. 
IR, UV, MS, and NMR spectra respectively were recorded on the 
following instruments: 
( i) Beckmann IR-33 spectrophotometer 
( ii) Hitachi Perkin-Elmer 124 spectrophotometer 
(iii) EAI QUAD-300 mass spectrograph 
( iv) JEOL JNM-4H-100 spectrophotometer. 
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2. Methods of isolation from natural sources  
(a) General extraction procedures  
For the various tissues and fluids studied, the choice of 
• extraction procedure depended on the weight given to such factors as 
quantitative recovery of lipids and solvent economy. Smell scale 
operations were carried out by a modification
37 
of the Folch procedure
38
, 
while the Bligh and Dyer method 39 was preferred for large scale 
extractions. In either case, traces of aqueous phase were removed by 
filtration through silicone-treated (Whatman 1-PS) paper. In general, 
95-99% recovery of the lipids was achieved; the losses were due mainly 
• to gangliosides and some polar glycolipids. 
(b) Preparation of milk sphingolipids  
The extraction of the lipids from whole milk requires large volumes 
of solvent
39
. An alternative procedure of freeze-drying followed by 
extraction avoided this problem, and the milk could be stored before 
extraction. 
The sphingolipids are preferably obtained from skim milk", 
although some polar lipids are concentrated in the fat globule membrane
41
. 
In the following procedure, whole fresh milk from Friesian cows was used. 
(i) Extraction of the total lipids  
Freeze-dried milk powder (155 g), containing about 35% lipid, was 
treated with four equal lots (10 of chloroform-methanol (2:1) and 
the combined extract partitioned with water (1)
38
. After standing 
overnight, the chloroform layer was dried over anhydrous magnesium 
sulphate, and the solvent removed under reduced pressure at 40°. 
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(ii) Preparation and fractionation of the polar lipids  
The removal of the bulk of the neutral lipids (glycerides, 
cholesterol esters, and cholesterol) was carried out by liquid-liquid 
partition42 . The residual lipids (50 g) were dissolved in the upper 
phase (120 ml) of a petroleum ether (40-60)-(87%) ethanol equilibrated 
mixture (50:50). This solution was then extracted twenty times with 
the lower ethanol phase (50 ml each). Monitoring by TLC showed that 
the phospho- and glyco-lipids were completely partitioned into the 
ethanol phase after six extractions. Ceramides, and other lipids of 
similar polarity required a further fourteen extractions for 95% of 
their removal. The combined ethanolic extracts were diluted with 
benzene and concentrated under reduced pressure to yield a lipid 
fraction containing about 30% phospholipids. The analysis of extracts 
was carried out by previously tested methods
40
. 
The separation of the phospho- and glyco-lipids from the neutral 
lipids and ceramides was carried out by column chromatography. 
Silicic acid, pretreated by washing out he fines with water
43
, was 
activated at 120°C for 2 hours immediately before use. The powder 
(100 g), slurried with diethyl ether (240 ml), was used to prepare the 
column (19 cm x 34 cm), as recommended for the isolation of lipid 
classes from 1-2 g of a mixture
44
. 
The polar lipid fraction (14 g) was dissolved in a small volume 
of diethyl ether, and applied to the top of the column. The neutral 
lipids were eluted (2-3 ml/min) with diethyl ether (400 ml) and 
discarded. The fraction containing ceramides was eluted with 
chloroform (150 ml) followed by chloroform-methanol (9:1, 100 ml), and 
set aside for further analysis (Fraction I). The phospho- and glyco- 
lipids were eluted with an increasing concentration of methanol in 
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chloroform (Fraction II), and subjected to mild alkaline hydrolysis to 
cleave ester bonds
45
. The sphingolipids were then isolated by 
preparative TLC. Cerebrosides and diglycosylceramides (yields, 
12 mg each) gave positive anthrone46 and negative phosphate47 tests. 
Some anthrone-positive material between the sphingomyelin and 
diglycosylceramide was observed in the position corresponding to 
sulphatides; on purification by TLC this fraction gave a stronger 
anthrone test, but there was not enough material for characterization. 
A third anthrone-positive peak in the elution pattern of buttermilk 
phospholipids was suggested to be triglycosylceramides 48 , by noting 
some similarities with blood serum glycosphingolipids 49 . The 
possibility of sulphatides was not mentioned 48 , but these compounds 
could be separated from oligoglycosylceramides if required
50
. 
(c) Preparation of brain sphingolipids  
Brain, second only to spinal cord, is the richest source of 
natural sphingolipids
51-53
, which comprise about 25% of its dry weight. 
The white matter contains cerebrosides, sphingomyelin, and sulphatides 
in the ratio 6:2:1, and is an excellent source of d18:1 31 ' 54 . The 
grey matter contains gangliosides and diglycosylceramides as well, 
and these contain relatively large quantities of d20:1 31 ' 55 
The dehydration and extraction of much of the cholesterol from 
a human brain was carried out with acetone essentially as described 51 . 
Ester-bound glycerophosphatides were hydrolysed with mild alkali
45
, and 
the sphingolipids recrystallised to remove some of the ether-bound 
glycerophosphatides. The procedures of using ether to remove 
glycerophosphatides 51 , and iodine in potassium iodide to cleave ether 
linkages
56
, were avoided as they lead to losses of sphingolipids. 
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(i)Dehydration of the brain  
Brain tissue (1.5 kg) was homogenised in a Waring blender and 
stirred overnight with acetone (2 t) at 4°. After centrifuging, 
the supernatant was poured off, and the solid treated overnight with 
more acetone (2 t). After decantation of the solvent the brain was 
dehydrated sufficiently to make filtration possible. The solid was 
re-extracted four times with acetone (1 t each) to yield a light 
brown solid (about 270 g). TLC of the acetone extracts revealed the 
presence of large quantities of cholesterol and other neutral lipids, 
with small quantities of glycolipids. 
(ii)Removal of glycerophosphatides  
The dry, solid residue obtained from the acetone dehydration was 
extracted with 2 lots, 1 k each, of hot chloroform-methanol (2:1), 
then with the same volume of hot chloroform-methanol (1:2). The combined 
extracts were taken to dryness under reduced pressure, and the lipid residue 
(130 g) refluxed for 10 minutes in dry methanol (1 t) containing fresh 
sndium (5 g). The solution was neutralised to phenolphthalein with 
anhydrous methanolic hydrogen chloride (1 N, about 220 ml), chloroform 
(2.5 k) added and partitioned with water (1 t). Salts and glyceride 
degradation products in the upper phase were removed by aspiration, and 
the lower phase evaporated to dryness (yield, 108 g). Recrystallisation 
from ethanol ydve an off-white powder (70 g), consisting essentially of 
sphingolipids. The removal of neutral lipid contaminants with non- 
polar solvents such as hexane or carbon tetrachloride resulted in a 
colloidal sphingolipid suspension which could not be centrifuged 
successfully. The preparation still contained small amounts of methyl 
esters, and degradation products of the plasmalogens and lyso-ethers. 
These could be removed, and the separation of the sphingolipids effected 
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by column chromatography
56
. 
(iii) Ceramides from brain sphingolipids  
With the exception of ceramides, sphingolipids are only partially 
hydrolysed with alkali, and undergo acid hydrolysis with difficulty 
resulting in relatively low yields of sphingoids and undesirable 
byproducts. Thus, a method for the conversion of total sphingolipids 
to ceramides would be advantageous. Sphingomyelins may be converted 
to ceramides by treatment with acetic acid-acetic anhydride
57 
or 
phospholipase C 56 . Sulphatides may be converted to cerebrosides by 
treatment with acetic acid
59 
or anhydrous methanolic hydrogen 
chloride
60
. In the author's experience the acetic acid-acetic 
anhydride treatment 57 was preferred owing to the simultaneous removal 
of the phosphorylcholine moiety from sphingomyelins and the sulphate 
group from sulphatides. A disadvantage of this procedure was that 
some hydrolysis of the amide bond occurred, producing diastereoisomeric 
N-acetyl sphingoids. 
Total brain sphingolipids (10 g) were heated with acetic acid-
acetic anhydride (4:1, v/v; 100 ml) under reflux for one hour. The 
solvent was removed under reduced pressure, and the residue treated 
with chloroform-0.6 N methanolic sodium hydroxide (1:1, v/v; 10 for 
one hour at room temperature
45
. Hydrochloric acid (0.6 N, 500 ml) was 
then added, the mixture shaken vigorously and the chloroform phase 
removed. This solution contained chiefly cerebrosides with smaller 
amounts of ceramides and N-acetyl sphingoids. The solvent was removed 
under reduced pressure (8.6 g of lipid recovered), and the cerebrosides 
were degraded to ceramides by the procedure of Carter, Rothfus and 
Gigg (1962)61. 
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(iv) Preparation of sphingoids  
The stereoisomers of sphingenine and sphinganine have been 
chemically synthesised
62-64 
However, the configuration of the 
sphingoids isolated from natural products can be determined by the 
hydrolytic procedure used. Acid or alkaline hydrolysis of t-ceramides 
produces t-sphingoids only (see Ch. 3, p. 90). Alkaline hydrolysis 
of e-ceramides produces e-sphingoids only
65
, but acid hydrolysis produces 
adiastereoisomeric mixture, with the e-isomers predominating
27
'
57 
To obtain the best yield possible of t-sphingoids by existing hydrolytic 
procedures, with a minimum of by-products , aqueous-methanolic 
hydrochloric acid (1 N) could be used 66 . 
Alkaline hydrolysis 61 of the ceramides from (iii) yielded 
essentially De-sphingoids (2.3 g, from 10 g of sphingolipids); small 
amounts of t-sphingoids, detected as DNP derivatives 31 , were found as 
a result of the dephosphorylation treatment. Recrystallization from 
ethyl acetate gave a light yellow wax, m.p. 60-70 0  (1.8 g). Its 
composition, determined by GLC (see p. 36, this chapter), was e-d18:1 
(86%), t-d18:1 (8%), e-d18:0 (3%), and other sphingoids (3%). 
Acid hydrolysis of the ceramides 66 , followed by N-acetylation 
of the sphingoids
67
, produced a mixture of mainly three derivatives 
which were separated by TLC on borate-impregnated TLC plates (solvent, 
chloroform-methanol (8:1)). The derivatives were characterised by 
IR spectroscopy, mass spectroscopy, and GLC; the sphingoid composition 
was thus determined as e-d18:1 (40%), t-d18:1 (33%), e-d18:0 (2%), 
and 3-0-Me-d18:1 (25%). The pure, isomeric sphingoids were obtained 
after alkaline hydrolysis 65 . A comparison of the sphingoid 
composition obtained after the above treatment, with that obtained 
after acid hydrolysis 66 of pure cerebrosides, was made. The sphingoid 
composition was, in the latter case, e-d18:1 (58%), t-d18:1 (20%), 
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e-d18:0 (2%), and 3-0-Me-d18:1 (20%). 
3. TLC Methods  
The versatile technique of TLC was used for the fractionation 
of natural lipid mixtures, also for the assessment of the purity of 
lipid preparations and the identification of individual constituents. 
It was also used for the monitoring of extractions and separations of 
columns. 
For the purposes of this work, the chromatographic adsorbent, 
silica gel G, was standardised. This is a white powder consisting of 
silicic acid (Si0 2 .xH 20) and contains anhydrous calcium sulphate as a 
binder. The structure of the former is regarded to consist of 
tetrahedral siloxane (Si.O.Si) units, with silanol (Si.OH) groups 
present at the surface
68
. A mono- or multi-molecular layer of 
adsorbed water covers the surface, but this "free" water can be removed 
reversibly by heating at 100 to 120°. The amount of free water present 
in the silica gel was found to influence the chromatographic mobility 
of compounds such as free ceramides
40
. 
(a) Preparation of plates  
A slurry of silica gel G in distilled water was applied to a 
metre-long rack of glass plates (20 cm x 5 to 100 cm) by means of a 
commercial applicator. Analytical plates (250 p thick) were prepared 
using a slurry of 33 g of silica gel in 60 ml of water. Preparative 
plates (1 mm thick) were prepared using a slurry of 100 g of silica 
gel in 175 ml of water. The plates were air-dried for 30 minutes, 
followed by activation for 1 hour at 110°. 
Chemicals were incorporated by using solutions in the place of 
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water. Sodium tetraborate (or simply "borate") impregnated plates 
were often used, and a 10% w/w loading of the chemical on the dry 
silica gel gave effective separations. These plates were stable 
indefinitely under normal laboratory conditions. Silver nitrate 
impregnated plates darkened quickly, and were best used immediately 
after activation; their preparation required a plastic spreader 
rather than the conventional brass spreader as the silver ion could 
displace the copper onto the plate. 
(b) Development  
Chromatograms were developed in rectangular glass tanks lined 
with solvent-saturated filter paper
69
. 
The solvents used for TLC were of analytical reagent grade; 
acetone and diethyl ether were redistilled. Two mixtures commonly 
used were 
( i) chloroform-carbon tetrachloride-methanol-water (50:50:12:0.5). 
(ii) chloroform-methanol-water (65:25:4) 79 . 
Many of the lipid materials used for TLC standards have been developed 
in either of these mixtures, and corresponding R f values tabulated 4 9. 
Solvent (i), useful for the analysis of ceramides and lipids of 
comparable polarity, gave more reproducible results than the 
chloroform-methanol mixtures usually used for the TLC analysis of 
ceramides
71
, also the presence of water increased the resolution of 
NFA and HFA ceramides. Solvent (ii) was used for the analysis of 
phospho- and glycolipids. 
Fresh solvent was necessary after the development of five to 
six chromatograms, as the more volatile components were lost; also, 
impurities were transferred from the adsorbent. 
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Cc) Visualisation  
The general reagent used for the detection of lipids was a 
solution of sulphuric acid (50%) containing potassium dichromate 
(0.5%)
72 
The solution was sprayed as a fine mist onto the plates, 
and the lipids charred by heating for 30 minutes at 250 0 . 
Lipids containing known functional groups were distinguished with 
the aid of specific reagents. Sensitive spray reagents are available 
for the detection of phosphorus
47
, sugar
46
, nitrogen
73
, ester
74
, free 
amino
75
, and vicinal diol
76
. 
The plates were photographed for permanent record. 
(d) Recovery of lipids from plates  
Non-destructive reagents such as iodine, water, or fluorescent 
indicators (e.g. dichlorofluoroscein) have been used for detecting 
lipids on TLC plates prior to their recovery. In this laboratory, 
eosin was found to be very sensitive to lipids at 254 nm, much more 
so than dichlorofluorescein. Its limit of detection was 0.5 pg of 
lipid (as pure ceramide or cholesterol) over 1 cm on an analytical 
plate. An aqueous solution (0.5%), sprayed as a fine mist onto the 
chromatogram, was adequate for the purpose. 
The portions of silica gel containing the desired compounds were 
marked under the UV light, scraped off the plate, and treated with 
chloroform-methanol (2:1). Silica gel au,i indicator were removed by 
washing the extract with one-third the volume of a dilute borate 
solution. The extract was filtered, and the solvent removed under 
reduced pressure. 
Preparative separations of compounds of comparable chromatographic 
mobility were carried out on layers 250 p thick, rather than the 1 mm 
layers conventionally used. The operation was time consuming, but 
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better separations were obtained (a possible reason for this is the 
difference in movement of a particular compound either near the 
surface of the adsorbent or near the glass plate). 
(e) Purification of natural ceramides  
The TLC analysis of natural ceramides in solvent (i) is rendered 
difficult by the presence of other lipids of comparable mobility, 
namely fatty acids and monoglycerides. As demonstrated (Fig. 1), 
fatty acids move closer to the NFA ceramides, while monoglycerides move 
with the HFA ceramides. Attempts to wash out the fatty acids from a 
chloroform-methanol (2:1) solution of the lipids with alkalis such as 
ammonia, sodium carbonate and sodium hydroxide solutions were 
ineffective. Neither could the monoglycerides be removed from total 
lipids by mild hydrolysis 45 . 
Silica gel plates impregnated with borate or arsenite ions were 
tested for their effect on the relative mobilities of the lipids, but 
resolution of major classes was not satisfactory by such methods. 
Borate retarded slightly the monoglycerides and the fatty acids moved 
with the NFA ceramides. Arsenite stopped the fatty acids from moving, 
but the monoglycerides moved with the NFA ceramides. 
The problem was solved by 2-dimensional TLC (Fig. 3, p.28). 
(i) Removal of the fatty acids  
The mobility of fatty acids relative to ceramides was influenced 
by the presence of alkalis or acids in the developing solvent. The 
solvent, chloroform-carbon tetrachloride-methanol-15N ammonium 
hydroxide (50:50:12:1) caused the fatty acids to stay near the origin, 
while the presence of acetic acid (1-2%) caused them to move close to 
the solvent front (Fig. 2). 
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Weak alkali such as sodium carbonate, added to the adsorbent, 
caused acidic components to remain at the origin. A convenient use 
of this method was that of applying a narrow band (0.5 cm wide) of the 
alkali immediately above the origin on a plate. Other lipids were 
not affected by the barrier, migrating quantitatively to their normal 
R
f 
values. 
A less convenient method to remove the fatty acids was by 
treatment with diazomethane. Methyl esters were produced 77 , which 
migrated to the solvent front on the TLC plates. This method was 
avoided, due to the toxicity of the reagent and its harmful effects 
on the basic phosphatides. 
(ii) Separation of the monoglycerides  
In general, chlorinated solvent-alcohol-water mixtures caused 
monoglycerides and HFA ceramides to move together on the plate (cf. 
Figs. 1,2). Substituting the chloroform for ether or the alcohol 
for acetone (or dioxan), influenced the relative mobilities of the 
ceramides and monoglycerides; the latter now moved with the NFA 
ceramides. Dry ether-acetone mixtures completely separated the 
lipids, but ceramide bands appeared diffuse and not as well resolved 
as they could have been had water been present in the solvent. 
The most effective solvent mixture was ether-acetone-15N 
ammonium hydroxide (30:20:2), which causec the monoglycerides to move 
near the NFA ceramides. The presence of the aqueous alkali not only 
removed fatty acids from the TLC system, but increased the resolution 
of the two ceramide bands. As the second solvent of a 2-0 
chromatographic system, with chloroform-carbon tetrachloride-methanol-
15N ammonium hydroxide (50:50:12:1) as the first solvent, monoglycerides 
were completely separated from NFA and HFA ceramides (Fig. 3). The 
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Fig. 1. TLC plate illustrating the relative mobilities of 
ceramides and some neutral lipids. Developing solvent, chloroform- 
carbon tetrauhloride-methanol-water (50:50:12:0.5). 1, NFA ceramides 
(upper spot), HFA ceramides (middle spot), and cerebrosides (lower 
spots); 2, ri-monoolein; 3, serum lipids; 4, oleic acid; 
5, cholesterol. 
Fig. 2. TLC plates illustrating the removal of fatty acids from 
ceramides and monoglycerides. Developing solvents for plates A,B, and 
C respectively were chloroform-carbon tetrachloride-methanol-15 N 
ammonium hydroxide (50:50:12:1), chloroform-methanol-acetic acid (95:5:2), 
and chloroform-carbon tetrachloride-methanol-water (50:50:12:0.5). A 
sodium carbonate band is present above the origin on plate C. 1, NFA 
ceramides (upper spot) and HFA ceramides (lower spot); 2, serum lipids; 
3, oleic acid. 
Fig. 3. 2-dimensional TLC plate illustrating the separation of 
ceramides from monoglycerides. Developing solvents for directions A 
and B respectively, chloroform-carbon tetrachloride-methanol-15 N 
ammonium hydroxide (50:50:12:1) and ether-acetone-15 N ammonium 
hydroxide (80:20:2). 1, cholesterol; 2, NFA ceramides; 
3, a-monoolein; 4, HFA ceramides; 5, oleic acid; 6, cerebrosides. 
Fig. 4. 2-dimensional TLC plate illustrating the separation 
of serum lipids. Developing solvents, as for Fig. 3. 1, cholesterol 
plus other neutral lipids; 2, NFA ceramides; 3, monoglycerides; 
4, fatty acids plus polar lipids. 
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method was used for the identification of these lipids in blood serum; 
NFA ceramides and monoglycerides were present, and HFA ceramides were 
absent (Fig. 4). Recovery of the fatty acids free from other lipids, 
could be achieved if desired by replacing ammonium hydroxide with 
water in the first solvent. 
(f) Spectrodensitometry of lipids  
The quantitative analysis of lipids may be carried out by 
spectrodensitometry. The accuracy is dependent on such factors as 
variation in thickness and degree of moisture of the adsorbent, the 
process used to apply the locating reagent, the shape and demarcation 
of the spots, and the distribution of components
78
. 
The variations in thickness became insignificant since 
commercially prepared plates were used. The moisture level was 
controlled using desiccated cabinets. 
The process used to apply the locating reagent was immersion 
after TLC
79
. This was found more practical than either spraying 
after TLC, or incorporation in the adsorbent before TLC
80-82 
The shape and demarcation of the spots were largely controlled . 
by lining theTLC tanks with filter paper. 
(i) Analysis of serum lipids using phosphomolybdic acid  
Commercially prepared silica gel G plates were prewashed with 
chloroform-methanol (2:1) in a TLC chamber. Sodium carbonate 
barriers were applied just above the origin and the plates dried at 
90 0  for 30 minutes. Lipids in chloroform were applied evenly over 
1.0 cm widths and 1.5 cm apart by means of a microsyringe. The 
plates were then developed in a suitable solvent system. After 
drying, they were immersed evenly and slowly into a solution consisting 
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of 5 g of phosphomolybdic acid in 70 ml of water, 25 ml of ethanol, 
and 5 ml of 70% perchloric acid 79 . The excess reagent was quickly 
removed with blotting paper, and the plates heated for exactly 20 
minutes at 85°. After cooling, the blue phosphomolybdate spots were 
scanned. 
Results obtained by this method were reproducible. Neither the 
reagent on the plates nor the colour of the spots deteriorated after 
4-5 days provided the plates were overlaid with a clean glass plate 
and stored in the dark. After several weeks, the plates protected 
with glass gradually assumed a blue colour, while plates exposed to 
the atmosphere returned to the original yellow colour within days. 
Standard calibration curves for cholesterol, ceramides, and 
monoglycerides are illustrated (Fig. 5). The method was sensitive, 
with lower limits of 0.05 pg for cholesterol, 0.1 pg for ceramide, 
and 0.5 pg for monoglyceride. The relationship, area = kCB, where C 
is the concentration 83 , did not fit the durves for cholesterol or 
ceramides. It will be seen that the densities of the spots vary 
significantly for the same concentration of the three lipids. This 
indicates other factors are involved in the reduction of the 
phosphomolybdic acid besides double bonds. It was shown that a 
saturated monoglyceride (a-monopaimitin) did not reduce the 
phosphomolybdic acid, either alone or when in the presence of natural 
monoglycerides or HFA ceramides. Thus hydroxyl, ester, and amide 
groups have no effect on the reagent under the conditions described. 
Tripalmitin and stearic acid showed no reaction either79 . 
In practice, cholesterol esters, triglycerides, diglycerides 
and cholesterol, are simply separated by TLC, and assayed by spectro-
densitometry. The analysis of ceramides or monoglycerides is more 
difficult, since spectrodensitometry measures the total concentration 
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Fig. 5. Spectrodensitometric analysis of cholesterol (curve A), ceramides 
(curve 8), and monoglycerides (curve C) with phosphomolybdic acid. 
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of these lipids which have similar chromatographic mobilities. To 
overcome this difficulty, one must look either to specific reagents or 
solvents that allow sufficient chromatographic separation. 
(ii) Analysis of serum monoglycerides  
Serum monoglycerides were analysed by spectrodensitometry of the 
coloured spots produced by their reaction with sodium metaperiodate 
and Schiff's reagents
76
. The colours did not deteriorate on standing 
for some time, and since the time for scanning was less than 1 minute, 
the results were reliable. 
A known quantity of normal serum lipids were applied to a 
commercially prepared plate. Milk monoglycerides, consisting mainly 
of monoolein, were used as standards. The plate was developed in 
chloroform-methanol (93:7),dried, and immersed slowly and evenly into 
a solution of sodium metaperiodate (1%). After 30 seconds, excess 
reagent was quickly removed with blotting paper, and the plate placed 
in a tank saturated with dry sulphur dioxide for 15 minutes. It was 
then sprayed lightly with Schiff's reagent and placed back into the 
tank for 1 hour. The coloured spots due to p-rosaniline were scanned 
immediately after removal from the sulphur dioxide atmosphere. The 
value, 5 mg %, was a typical value for normal serum monoglycerides 79 . 
(iii) Analysis of serum ceramides 
Serum ceramides were analysed by spectrodensitometry of the 
coloured spots produced by their reaction with t-butylhypochlorite and 
potassium iodide-starch reagents
73
. The plates darkened within 
minutes on exposure to the atmosphere, and iodine was lost from the 
spots. However, consistent results were obtained with standards 
subjected to the same conditions provided that analysis was carried 
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out without delay. 
A known quantity of the serum lipid was applied to a silica gel 
plate, prepared as described previously; commercially prepared plates 
were found unsuitable for this method. NF A ceramides were used as 
standards. The plate was developed in chloroform-methanol (93:7), 
dried, and sprayed evenly with a solution of t-butylhypochlorite in 
cyclohexane (2%). After drying under a cold air blast for 1 hour, 
the plate was sprayed lightly with a solution of KI-starch (1%) and 
the coloured spots scanned immediately. Values of 1 mg% for NFA 
ceramides and 0.04 mg% for HFA ceramides were obtained. 
4. 	GLC Methods  
GLC was used for three purposes, for long-chain methyl ester, 
N-acyl sphingoid, and amino acid analyses. 
(a) Analysis of methyl esters  
Methyl esters, both saturated and monounsaturated, were analysed 
by GLC on 3% GE SE-30 (GC grade) on Gas Chrom Q contained in silanized 
glass columns (3 mm ID by 2 m). Polyunsaturated methyl esters were 
distinguished on a column of 3% EGSS-X on Gas Chrom Q. Columns were 
conditioned for 36 hours at temperatures near the upper limits for the 
liquid phases. 
GLC operating conditions  
Initial temperature, 160° 
Final temperature, 310° 
Programming rate, 5°/minute 
N
2 
and H
2 
flow rates, 20 ml/minute 
Air flow rate, 250 ml/minute 
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Detector temperature, 310° 
Injector temperature, 310° 
Using the above operating conditions, the relative retention times 
of some unsubstituted methyl esters (A), 2-trimethylsiloxy methyl 
esters (B), and 2-acetoxy methyl esters (C) have been recorded (Table 
2). The direct relation observed between the carbon number and 
relative retention time (Fig. 6) permits extrapolation or interpolation 
so as to determine the retention times of other methyl esters. 
Table 2  
Retention times of methyl esters, relative to methyl stearate (18:0) 
Carbon no. A B C 
12:0 0.27 - 
14:0 0.47 0.77 - 
16:0 0.73 1.02 0.19 
18:0 1.00 1.29 0.38 
. 20:0 - 1.27 1.55 
0.59 
22:0 1.53 1.78 0.86 
24:0 1.78 2.01 1.13 
26:0 2.07 2.23 1.34 
18:1 1.05 - - 
18:2 0.96 - - 
18:3 0.96 - - 
20:1 1.23 - - 
22:1 1.50 - - 
24:1 1.75 2.20 - 
12 14 
I 	I 	I 	t 
20 22 24 26 
and 2-trimethylsiloxy methyl esters (curve B), 
2.4 
RELATIVE 
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• 
• Fig. 6. 
	
	Retention times of saturated relative to methyl stearate. 
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(b) Analysis of N-acyl sphingoids  
N-acyl sphingoids (ceramides), including N-acetyl sphingoids, 
were analysed as their TMSi ethers by GLC on a column (3.3 mm by 3 m, 
glass) containing 1% GE SE-30 (GC grade) plus 1% OV-17 on Gas Chrom Q. 
A column of 1% OV-1 on Gas Chrom Q, which has been favoured for 
separating homologues of e-ceramides
84
, gave equally effective 
separations. The relative retention times of diastereoisomeric 
ceramides were similar to those observed for the N-acetyl analogues, 
separated on the above columns, or on 3.8% SE-30 on Diatoport S
85 
(a study of stereoisomers is given in Ch. 3). 
Derivatisation of the N-acyl sphingoids prior to GLC was 
accomplished by treatment for one hour with SIL-PREP (200 pg of lipid 
was treated with 100 pt of reagent). N-acetyl derivatives were 
analysed in the reagent, while ceramide derivatives were analysed in 
carbon disulfide after removing the reagent under reduced pressure 
with an oil pump 
86
. 
The carrier gas used was helium rather than nitrogen, since this 
has been found to increase thc resolution of ceramide derivatives, 
and give a better relative detector response 84 . 
GLC operating conditions  
Column temperatures were 220° or 300°, for N-acetyl sphingoid or 
ceramide derivatives, respectively (the latter could be separated on 
1% OV-1 on Gas Chrom Q at 280° with similar retention times). 
Detector temperature, 280° 
He flow rate, 50 ml/min. 
H
2 
flow rate, 40 ml/min. 
Air flow rate, 300 ml/min. 
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Table 3  
Retention times of TMSi derivatives of diastereoisomeric N-acyl 
sphingoids, relative to the isomer derived from e-d18:0 
Sphingoid moiety 
in derivative 
N-acetyl 
derivative 
N-stearoyl 
derivative 
t-d18:1 
t-d18:0 
e-d18:1 
e-d18:0 
3-0-Me-d18:1 
2D,3D,4D-t18:0 
0.84 
0.87 
0.93 
1.00 
1.10 
1.20 
0.85 
0.89 
0.93 
1.00 
   
The actual retention time for the derivatives containing e-d18:0 was 
about 16.5 minutes. 
(c) Analysis of amino acids  
Amino acids were converted to their TMSi derivatives, and analysed 
by GLC essentially as described 87 . The column consisted of 10% OV-7 
on Gas Chrom Q contained in glass columns (3.3 mm ID by 3 m), and gave 
separations similar to those obtained on a column containing less 
liquid phase. 
GLC operating conditions  
Initial temperature, 75°. 
Final temperature, 290°. 
Programming rate, 4°/minute. 
N
2 
flow rate, 60 ml/minute. 
H2 
flow rate, 40 ml/minute. 
Air flow rate, 300 ml/minute. 
Detector temperature, 280°. 
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In the accompanying table (Table 4), retention times are given 
relative to phenanthrene. The structures of amino acid derivatives 
have been recorded
87
. Amino acids that can contain 2,3 or 4 TMSi 
groups are given numbered subscripts. 
Table 4  
Retention times of TMSi derivatives of amino acids, relative to phen-
anthrene 
Amino acid derivative Relative retention time 
Alanine 0.36 
Glycine 2 0.39 
Val me 0.47 
Leucine 0.52 
Isoleucine 0.55 
Glycine3 0.56 
Proline 0.57 
Serine 0.61 
Threonine 0.63 
Hydroxyproline 0.74 
Aspartic acid 0.75 
Methionine 0.76 
Cysteine 0.78 
Arginine3 0.78 
Glutamic acid 2 0.78 
Glutamic acid3 0.82 
Phenylalanine 0.84 
Lysine3 0.92 
Arginine4 0.95 
Lysine4 0.98 
Histidine2 1.01 
Tyrosine 1.03 
Histidine3 1.05 
Tryptophan 3 1.21 
Cystine 1.25 
Tryptophan 2 1.25 
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CHAPTER 2  
LIPIDS ASSOCIATED WITH OR DERIVED FROM CERAMIDES 
1. Polyol artefacts in KL ceramides  
Ceramides, prepared from mono-, di-, or trihydroxy e-sphingoids, 
and normal or racemic 2-hydroxy fatty acids, have been analysed by 
TLC
71,88
. Natural ceramides, differing in the number, position, 
and stereochemistry of hydroxy groups
89,90 
and the fatty acid . chain 
length
91
, have also been studied. Silver ions added to the adsorbent 
causes the separation of ceramides differing in the degree of 
unsaturation45 ' 92 ; for distinguishing between derivatives containing 
either e-d18:1 or e-d18:0, borate has been used
93
. Observations of 
chromatographic spots that could not be interpreted on findings listed 
above gave rise to investigations reported in this section. 
The low R
f 
values suggested polar groups in excess of those 
normally found in ceramides. Of particular interest were two 
compounds with R f values of 0.25 and 0.20 (Fig. 1, lane 2) observed 
in some KL ceramide preparations . The polyols described by 
Hammarstrom
92 
have similar R
f 
values, but other possibilities cannot 
be excluded. Serum lipids in sufferers from heart disease have 
constituents of the same chromatographic mobility; these were 
considered to belong to a class of ceramicies with additional hydroxy 
groups on either the fatty acid or sphingoid moeities 2 . Ceramides derived 
from t18:0 belong to this class (lanes 3 and 4), and these have been 
found in small concentration in animals
90
. 
A sample of the KL ceramide was separated by preparative TLC into 
the four lipid classes tentatively regarded as "ceramides 1,2,3 and 4" 
in order of decreasing R f values
94 ; the solvent for TLC was chloroform- 
Fig. 1. TLC plate illustrating the relative mobilities of 
ceramides and cerebrosides. Developing solvent, chloroform-carbon 
tetrachloride-methanol-water (50:50:12:0.5). 1, KL ceramides, pure; 
2, KL ceramides (batch No. 43209), with the show-moving compounds; 
3, 24:0-t18:0; 4, D-h16:0-t18:0; 5, cholesterol (upper spot) and 
cerebrosides (lower spots). 
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methanol (92:8). The following methods (a) to (e) proved that 
"ceramides 1 and 2" were respectively NFA and HFA derivatives of 
d18:1, and that "ceramides 3 and 4" were respectively NFA and HFA 
derivatives of the sphingoid 
CH 2OH 
CH3 (CH 2 ) 12CH=CH-CH-CH-CH 2-0-CH-O-CH-CH 2OH 
I I 
OH NH2 	— ICH2OH 
(a) IR spectroscopy  
The IR spectra of the four ceramide classes were alike; 
-1 
"ceramides 3 and 4" showed a stronger v C-0(1050-1040 cm ) which 
indicated a higher content of primary hydroxyl groups. The C-H out- 
of-plane deformation (960 cm
-1
) for the trans double bond indicated 
the presence of d18:1. 
(b) Conversion of cerebrosides to polyols  
Degradation of KL cerebrosides
61
, followed by TLC
92
, afforded 
polyols which had the same chromatographic mobilities as "ceramides 3 
and 4". Mild acid hydrolysis 61 of these compounds produced "ceramides 
1 and 2" respectively. 
(c) Analysis of the sphingoids by mass spectroscopy  
Strong ,i.kaline hydrolysis of the ceramides 93 yielded sphingoids, 
which were converted to TMSi-N-acetyl sphingoids 67 . The mass spectra 
for the derivatives obtained from "ceramide 1" (Fig. 2), "ceramide 2" 
(not shown), and KL sphingenine (Fig. 3) were essentially identical. 
With the exception of minor peaks due to 1,3-di-0-TMSi-N-acetyl d18:0 
(compared with a pure sample in Fig. 4), the spectra were similar to the 
published one for 1,3-di-0-TMSi-N-acetyl d18:1
67
. The absence of 
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peaks due to 1,3,4-tri-O-TMSi-N-acetyl t18:0 was verified by comparison 
of the spectra with a published one for this derivative 95 . The mass 
spectral fragmentation modes for the above derivatives follow those 
proposed for other TMSi-N-acyl sphingoids84 ' 96 , and will not be 
discussed here. 
The spectra for the derivatives obtained from "ceramide 
(Fig. 5) and "ceramide 4" (not shown) have a prominent peak at m/e 311 
which also occurs for the derivative obtained from d18:1 (Fig. 3). 
Some other fragmentation modes are represented in Fig. 5, together 
with the structure, for these derivatives. Two mechanisms which 
account for some of the observed ions have been ascribed to the effects 
of the radical and positive ion sites, respectively
97
. If A 
represents the sphingenine part of the molecule, and B the polyol part, 
then the two mechanisms may be represented as follows: 
+ 
A-CH
2 -0'-B A + CH2
=0-B   ( i) 
+L 
A-CH
2
-0
i
'-B A-CH
2
-0' + B
+ 
 (ii) 
Ions at m/e 396 and m/e 398 for the sphingenine and sphinganine 
derivatives respectively may thus be proposed. 
R-CH-CH-CH
2 
 -0-CH   R-CH-CH-tH
2 
+ 0-CH 
I I  II 
RTMSiO NH RTMSiO NH 
1 1 
COCH
3 COCH3 
Other ions due to mechanism (ii) occur at m/e 351, m/e 319, m/e 396 
or 398 and m/e 262 (the latter due to loss of trimethylsilanol from 
the ion at m/e 351). An ion expected at m/e 452 for cleavage between 
C
2 
and C
3 of the sphingenine moeity, with charge retention on the 
fragment containing the acyl moeity, does not appear. However the 
ions at m/e 306 and We - 216 may result from secondary rearrangements, 
100 20 500 300 4 0 
1 
)4. d 4 
73 
* 
.Si(CH3)3 
57 43 18 
---0.1 ( e 
a 1 -----* 
1 
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' I 'I [M-(a-73)-90] 
TMSiO NH 	 157 	 , 
-CH2CH2t 	1 lb (m-d) (M-a) 311 129 c : COCH3 
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85 
103. 
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Fig. 2. Mass spectrum of the di-O-TMSi-N-acetyl sphingoids derived from KL "ceramide 1". 84 
The symbols used to indicate fragments are the same as those used by Samuelsson and Samuelsson. 
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with losses of two trimethylsilyl radicals followed by a trimethyl-
silanol molecule, respectively. 
(d) Analysis of the sphingoids by GLC  
The TMSi-N-acetyl sphingoids derived from the ceramides were 
analysed by the GLC method previously described (p. 36). "Ceramides 
3 and 4" respectively were converted to "ceramides 1 and 2" before 
analysis. The two main sphingoids present in each ceramide were 
e-d18:1 and e-d18:0; these were present in the ratio 97:3 approximately. 
Other sphingoids occurred in traces and were ignored. 
(e) Analysis of the fatty acids  
The fatty acids derived from the ceramides after hydrolysis 93 
were converted to methyl esters
98
, and analysed by GLC as previously 
described (p. 36). The NFA derivatives ("ceramides 1 and 3") and 
HFA derivatives ("ceramides 2 and 4") respectively gave fatty acid 
compositions (Table 1) similar to those derived for cerebrosides 
(Table 2). The major fatty acids are, in decreasing order of 
importance, 24:1, 24:0, and 18:0 for NFA ceramides, and h24:0, h24:1, 
and h18:0 for HFA ceramides. For sphingomyelin (Table 2), 18:0, 
24:1, and 24:0 are the major fatty acids, in decreasing order of 
importance. 
The fatty acid compositions of bovine brain cerebrosides and 
sphingomyelin have been previously recorded, and are essentially the 
same as those observed here but for the absence of the longer chain 
fatty acids (C26 to C30) 99 . Such fatty acids have been found in 
human brain"°. 
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Table 1  
Fatty acid composition of KL ceramides weight %) 
Fatty acid "Ceramide 1" "Ceramide 	" "Ceramide 2" "Ceramide 4" 
12:0 0.2 trace 0.1 0.1 
14:0 0.4 0.4 0.2 0.3 
15:0 0.1 trace - 0.2 
16:0 5.0 3.9 1.1 0.1 
16:1 - - trace - 
17:0 0.1 0.1 trace - 
18:0 11.9 10.7 15.3 14.6 
18:1 0.4 0.3 0.6 0.2 
18:2 1.6 0.2 - - 
19:0 trace 0.1 0.7 0.5 
20:0 1.4 1.3 1.3 1.0 
20:1 0.7 0.3 0.5 0.2 
21:0 0.1 0.1 0.1 0.2 
21:1 - - - - 
22:0 5.5 5.8 7.6 2.3 
22:1 - trace - - 
23:0 5.8 5.8 8.4 7.3 
23:1 0.2 0.2 0.3 - 
24:0 21.3. 20.0 28.1 31.0 
• 24:1 32.6 31.1 16.1 16.2 
25:0 2.2 2.3 4.0 3.5 
25:1 1.3 0.9 1.8 0.5 
26:0 3.1 3.3 5.5 4.2 
26:1 5.1 3.5 5.3 1.0 
27:0 0.2 4.3 0.7 6.9 
27:1 0.4 0.1 trace - 
28:0 0.1 0.6 0.2 0.8 
28:1 0.3 2.6 0.6 4.0 
29:0 trace 1.5 0.5 2.6 
29:1 - 0.3 trace 0.5 
30:0 trace 1.9 0.3 1.5 
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Table 2  
Fatty acid composition of bovine brain sphingolipids (weight %) 
Fatty acid Sphingomyelin NFA cerebrosides HFA cerebrosides 
12:0 0.1 trace 
14:0 0.1 trace 0.2 
15:0 0.4 0.1 
16:0 2.9 0.3 0.3 
16:1 
17:0 0.2 
18:0 36.8 10.7 16.3 
18:1 0.5 1.9 
18:2 0.3 
19:0 0.3 0.4 0.4 
20:0 0.7 2.4 1.6 
20:1 
21:0 0.1 0.4 0.6 
21:1 
22:0 2.8 15.3 5.6 
22:1 0.5 1.4 0.8 
23:0 2.4 6.0 7.5 
23:1 1.1 1.8 1.0 
24:0 8.8 15.4 37.5 
24:1 26.1 30.1 13.6 
25:0 2.4 2.5 4.6 
25:1 4.8 2.3 1.3 
26:0 2.2 2.8 4.0 
26:1 5.0 4.2 3.3 
27:0 0.3 0.5 0.4 
27:1 0.6 0.5 0.5 
28:0 0.3 0.9 0.8 
28:1 0.5 1.0 
29:0 
29:1 
30:0 trace 
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2. Lipids accompanying natural ceramides  
Other workers with serum ceramides
101 
recorded relatively high 
amounts of C12 to C18 fatty acids, which are not usually found in such 
natural ceramides
102
. This suggested that contaminating fatty acids 
and monoglycerides have been overlooked. The relative chromatographic 
mobilities of these lipids, and their separation by special TLC 
techniques, have been described previously (p. 25). In TLC solvents 
containing chloroform and methanol, monoglycerides and HFA ceramides 
have similar chromatographic mobilities. However, only HFA ceramides 
were isolated by TLC from serum lipids 2 . Proof of the structures of 
the lipids which contaminate natural ceramides on TLC plates has been 
provided in the case of milk lipids; their isolation was carried out 
by preparative TLC. 
(a) Identification and analysis of the fatty acids  
The chromatographic mobility of the lipid fraction similar to 
that of NFA ceramides is ascribed to fatty acids. The IR spectrum 
of the fraction (Fig. 6) was practically identical to that of oleic . 
acid, with absorption occurring at 3000 q, 2400 cm -1 , 1710 cm 
-1 -1 
1280 cm for the carboxyl group, and 3000 cm for the double bond. 
-1 
A weak band occurring at 1550 cm could be an N-H deformation mode 
due to the presence of associated amino acids; ceramides are excluded 
by the absence of a C=0 stretch at 1660 cm -1 , and by the fact that 
their concentration in milk is very small
103
. 
The fatty acids were converted to methyl esters
98 , and analysed 
by GLC as previously described (p. 33). The composition was 18:1 
(84%), 16:0 (14%), and 14:0 (2%); these are the major fatty acids of 
milk triglycerides. 
51 
(b) Identification and analysis of the monoglycerides  
The chromatographic mobility of the lipid fraction similar to 
that of HFA ceramides is ascribed to a-monoglycerides. The IR 
spectrum of the fraction (Fig. 7) was similar to that of synthetic 
a-monopalmitin, with absorption occurring at 3360 cm  v 0-H, 
1740 cm
-1 
for v C=0, 1150 cm
-1 
for the secondary v C-0, and 1100 cm -1 
for the primary v C-0. The fraction gave positive colour tests for 
ester74 and vicinal dio1 76 on the plate, and a negative colour test for 
nitrogen
73
. 
The purity of the fraction was checked by carrying out colorimetric 
analyses for glycerol
104
, vicinal diol
105
, and the number of ester 
groups
106
. The values obtained respectively, per mg of lipid, were 
2.30 mmole, 2.10 mmole, and 2.38 mmole. The 1:1 correspondence 
between these values gave an indication of a-monoglycerides, although 
the slightly lower value for vicinal diol indicated the presence of 
some f3-monoglycerides which may have formed during TLC107 . Pure 
a-monoolein gave values of 2.80 mmole/mg, indicating that the fraction 
was 85% pure; the impurity wa found to be mostly fatty acid. 
3. Lipids derived from ceramides and related compounds  
The ageing of ceramides suggests oxidation and/or reacylation. 
Of these two, the latter received more attudtion, as it occurred even 
when precautions were taken against the former. 
(a) The stability of acyl sphingoids  
The non-reactivity of ceramides in chloroform-methanol (2:1) 
solution, after standing for three weeks at room temperature, has been 
n.50 
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Fig. 6. IR spectrum of free fatty acids derived from milk. 
1175 
1105 	1040 
1460 
Af 
3800 	3000 	 2000 	1800 	1600 	1400 	1200 	1000 
WAVENUMBER, CM 
Fig. 7. IR spectrum of monoglycerides derived from milk. 
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noted
108
; during this time little or no change was detected on TLC 
plates. In this laboratory, similar experiments were conducted, with 
comparable results. Ceramides, stored either dry, in chloroform 
solution at 00 , or in chloroform solution at room temperature in the 
presence of sodium hydrogen carbonate or traces of sodium hydroxide, 
did not give any anomalous TLC spots during a period of three years. 
However, on TLC plates impregnated with borate, a minor component 
below the ceramides was observed when testing solutions which had been 
standing at room temperature for several months. As addition of 
ammonia or strong alkali to the solution did not remove the minor 
component, it was not an 0-acyl sphingoid. Alkaline hydrolysis gave 
t-18:1, suggesting some inversion of the original ceramides. This 
may have been brought about by the action of a trace of hydrochloric acid 
formed in the ageing chloroform, although ceramide solutions containing 
added hydrochloric acid did not appreciably accelerate the process. 
The addition of hydrogen chloride to a dry ether solution of ceramides 
produced some 0-acyl sphingoids, but unlike the reaction with 
N-palmitoy1-1-(p-nitropheny1)-2-amino-1,3-propanediol
109
, addition and 
hydrolysis products were also formed. 
0-acyl sphingoids were stable when stored dry, but in chloroform 
solution at 00 isomerisation to the N-acyl compounds was complete 
after several weeks. 
(b) Natural ceramides and related con younds  
Ceramides have been found in nearly every type of tissue of animal 
origin, and in most cases, the relative concentration is small. 
Hence the study of compounds related to ceramides in lipids from 
plasma, erythrocytes, liver, kidney, brain, spleen, aorta, and lung, 
was found to be impractical. Platelet lipids, which are rich in 
55 
, 
ceramides (0.5 to 1.3% 
wit0110111 
 and relatively poor in neutral 
lipids, were potentially the most practical source. Platelet 
ceramides also have a high turnover rate
112
. 
The platelets obtained from ox blood (5 t)
110 
were extracted
38
, 
and the lipids tested for ceramides and related compounds by TLC 
(Fig. 8). As observed (lane 2), NFA ceramides are resolved into 
three components (probably due to differences in the fatty acid moeity), 
while compounds corresponding to HFA ceramides appear as two components. 
The results obtained by adding ammonia to the lipid solution were not 
conclusive in suggesting the presence of small amounts of 0-acyl 
sphingoids in platelets, since the TLC plates appeared much the same 
before and after treatment (except for acidic components). The two 
components corresponding to HFA ceramides were respectively found to 
be monoglycerides, and possibly HFA ceramides, by 2-dimensional 
chromatography (p. 26); the latter has not been observed before in 
platelets. 
On other TLC plates, sphingoid-oxazolines were not found in 
platelet lipids after the removal of interfering glycerides with mild 
alkali
45
. 
(c) Starting materials for oxazolines  
The preparation of oxazolines from sphingoids, acyl sphingoids or 
related compounds was attempted by three methods: 
i) dehydration of N-acyl derivatives; 
ii) condensation of ..-hydroxyamino acid esters with imidic 
acid ester hydrochlorides; 
iii) condensation of sphingoids with imidic acid ester 
hydrochlorides. 
Fig. 8. TLC plate illustrating ceramides from  ox platelets. 
Developing solvent, chloroform-carbon tetrachloride-methanol-water 
(50:50:12:0.5). 1, cholesterol (Rf 0.64), ceramides (Rf 0.50, 0.35), 
and cerebrosides (Rf 0.12, 0.09); 2, platelet lipids; 3, sphingoid-
oxazolines (Rf 0.80, 0.70) and acyl sphingoids (Rf 0.50, 0.45). 
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i) Dehydration of ceramides and related compounds was 
attempted with thionyl chloride. Of the compounds tested, only 
threonine and allothreonine derivatives containing long-chain fatty 
acyl groups formed oxazolines without side reactions (N-phenyl 
analogues gave similar results
113
). Ceramides and N-acyl phenyl- 
serinols gave a-chloro substituted oxazolines; phenylserine 
derivatives produced no oxazoline at all, but only a-chloroamides. 
From these results, use of thionyl chloride as a dehydrating agent 
would appear unsuitable for the preparation of oxazolines from amides 
with a a-hydroxy group in the benzylic or allylic positions
114,115. 
ii) The condensation of a-hydroxyamino acid esters with either 
aliphatic or aromatic imidic acid ester hydrochlorides gave oxazolines 
in quantitative yields. The reaction using free imidic acid esters 
and a-hydroxyamino acid ester hydrochlorides gives relatively low 
yields 116 , and was not used. Reduction of the ester group to the 
alcohol could be carried out successfully with lithium aluminium 
hydride; the double bond of the ring was not affected under the 
conditions used, although 2-alkyl oxazolines of a similar nature have 
been stated to be susceptible to attack by this reducing agent. 
The preparation of long chain alkyl a-hydroxyamino acid analogues 
would be advantageous because of the high yields of oxazolines, and 
the unambiguous nature of their synthesis. Also, the configuration of 
the oxazolines may be determined by using Elliot's observation that 
sodium ethoxide catalyses the transformation of cis- to trans- 
oxazolines
116,117
. The preparation of the isomers of a-amino-0- 
hydroxystearic acid by methods other than existing ones
118,119
, was 
attempted. Copper II-Schiff base chelates have been successfully 
condensed with short chain aldehydes under base-catalysed conditions, 
120,121 
producing a-hydroxyamino acids in yields usually greater than 60% 
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The reactions were carried out in either water or methanol in which 
thereactants were soluble. In the present work, yields of the 
derivatives were found to be low, owing to the insolubility of the 
aldehydes in the reaction media. 
iii) Sphingoids were found to condense with imidic acid 
ester hydrochlorides in good yield (60-80%). The presence of the 
three adjacent functional groups available for reaction led to a 
mixture of oxazolines which required methods for their separation 
and characterisation. These aspects are discussed in the next 
section. 
(d) The chemistry of sphingoid-oxazolines  
The reaction scheme (Fig. 9) for the preparation and degradation 
of sphingoid-oxazolines illustrates four isomeric compounds (I), (II), 
(III), and (IV) which may be derived from the condensation of e- and 
t-sphingoids with imidic acid ester hydrochlorides. It was found 
that (I) and (III) were the.major products of the synthesis, and (II) 
and (IV) the minor products. Solutions of the oxazolines displayed 
an equilibrium in which the more stable isomers were favoured (see 
Ch. 3, p. 91). 
Purification of a mixture of the oxazolines could be carried out 
by recrystallization from ethanol, or by preparative TLC followed by 
recrystallization of the oxazoline (I). 
Under mildly acidic conditions 122 , the oxazolines (I) and (III) 
were unstable, yielding the acid salts of the 0-acyl sphingoids (V) 
and (VI), respectively. On careful treatment with ammonia to pH 
5_6116, the free 0-acyl sphingoids (VII) and (VIII) were obtained. 
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Fig. 9. Reaction scheme for the preparation and degradation of sphingoid-oxazolines. 
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The addition of more ammonia to pH 8 or greater caused the acyl group 
to migrate, and the ceramides (IX) and (X) were isolated without change 
of configuration. 
The position of the free hydroxyl group in the oxazolines (I, II, 
III, or IV) may be verified by examining the periodate oxidation 
products
123
. Ring cleavage and oxidation were carried out with 
periodic acid in pyridine
124
. The aldehydes liberated, and those 
liberated from either d18:0 or d18:1 were compared on TLC plates 
(developing solvent, hexane-diethyl ether (9:1))125. Hexadecan-l-al 
(Rf , 0.50) and trans-2-hexadecen-l-al (R f , 0.41) were produced from 
d18:0 and d18:1 respectively, and only the oxazolines (I) and (IV) gave 
these aldehydes (XIII). The oxidation products of the oxazolines 
(III) and (II) did not show TLC spots corresponding to these aldehydes, 
and presumably the compounds (XIV) were produced. 
The spectroscopic, chromatographic, and stereochemical differences 
in the products illustrated in Fig. 9 are treated in Chapter 3. 
(e) Oxidation of ceramides  
• Unsaturated lipids can be susceptible to photooxidation and 
autoxidation under normal storage conditions, the latter can be 
prevented by storing lipids either dry or in solution, under nitrogen, / 
and by using antioxidants. During TLC, lipids are quite stable to 
autoxidation
126
. 
The photooxidation of lipids has not been critically investigated. 
Hence, experiments were conducted to assess the effects of various 
conditions, especially those under which one works normally in the 
laboratory, on lipid residues. It was found that unsaturated lipids 
exposed to natural light gave reaction products of slower chromato-
graphic mobility than the parent lipids; the reactivity increased as 
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the degree of unsaturation increased. The photooxidation of 
ceramides, and some common neutral lipids, are illustrated in Fig. 10 
•and Fig. 11, respectively. The parent lipids had been applied to the 
origin of the TLC plate, and exposed to subdued sunlight for one day; 
similar results were obtained for lipids finely dispersed on a watch- 
glass. Negative results were obtained for saturated lipids, or lipids 
stored in the absence of sunlight under normal laboratory conditions 
(or in pure oxygen, either dry or saturated). 
4. Experimental  
(a) Attempted dehydration of compounds related to ceramides  
( i) Phenylserine  
Benzaldehyde (400 g) was added with stirring to glycine (150 g) 
and sodium hydroxide (120 g) in water (500 ml) at 5-10° and allowed to 
stand overnight. The crude product was macerated, treated with 
concentrated hydrochloric acid (250 ml), cooled in ice overnight, 
filtered, and recrystallized from aqueous ethanol. The yield was 
260 g (71%), and its m.p. was 194-5° as reported 127 . 
( ii) Phenylserine ethyl ester  
Hydrogen chloride was bubbled for several hours through a 
suspension of phenylserine in dry ethanol. The solution was 
concentrated under reduced pressure yielding the hydrochloride salt of 
phenylserine ethyl ester (m.p. 132° after washing with dry ether). 
This was dissolved in ice-cold water, excess potassium carbonate added, 
and the free ester extracted with ether. The product, recrystallized 
twice from ether, melted at 82°. On another occasion the same sequence 
of steps gave a product which melted at 87°. Both products were pure, 
as indicated by their homogeneity on TLC plates, NMR spectroscopy, and 
Fig. 10. TLC plate illustrating some photooxidation products 
of ceramides resulting from exposure to subdued natural light for one 
day (lanes 2-6). Developing solvent, chloroform-carbon tetrachloride- 
methanol-water (50:50:12:0.5). 1, KL ceramides (freshly applied); 
2, NFA ceramides, natural mixture; 3, HFA ceramides, natural mixture; 
4, 24:0-De-d18:1; 5, 24:1-De-d18:0; 6, 24:0-De-d18:0. 
Fig. 11. TLC plate illustrating some photooxidation products of 
neutral lipids (lanes 2-7). Developing solvent, chloroform-carbon 
tLtrachloride-methanol-water (50:50:12:0.5). 1, cholesteryl oleate 
(Rf 0.80), methyl oleate (Rf 0.73), and cholesterol  (Rf 0.57), freshly 
applied; 2, cholesteryl oleate; 3, methyl oleate; 4, cholesterol; 
5, oleic acid; 6, monoolein; 7, triolein; 8, triolein (Rf 0.80), 
oleic acid (Rf 0.45), and monoolein (Rf 0.35), freshly applied. 
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elemental analysis. The literature gives a melting point of 138°, 
and assumes that it is the t-isomer
127
. The results obtained here 
indicate that its diastereoisomer may also be present (Analysis: 
C, 63.1; H, 7.2; N, 6.8%. Calcd. for C, 63.1; H, 7.2; 
N, 6.7%). 
(iii) DLt-phenylserinol (DLt-l-phenyl-2-amino-1,3-propanediol) 
Phenylserine ethyl ester (10 g) in dry ether (400 ml) was treated 
with lithium aluminium hydride. The viscous liquid obtained was 
recrystallized from ether to give t-phenylserinol, m.p. 88° (as 
reported
127
), in 30% yield (2.4 g)(Analysis: C, 64.7; H, 7.8; 
N, 8.3%. Calcd. for C 9H 1302N: C, 64.7; H, 7.8; N, 8.4%). The 
4 
remainder, consisting most likely ofe-phenylserinol, could not be 
induced to crystallize. 
( iv) N-stearoyl phenylserine ethyl ester; reaction with SOC1 2 
Stearoyl chloride
128 
(0.01 mole, or 3.03 g) in N,N-dimethyl-
formamide (10 ml) was added slowly to a solution of phenylserine ethyl 
ester (0.01 mole, or 2.093 g) in N,N-dimethylformamide (30 ml) and 
triethylamine (2 ml), and the solution stirred for two hours at room 
temperature. The reaction mixture was then added to an ice-water 
mixture (200 ml), acidified with dilute hydrochloric acid, and the crude 
product filtered and washed thoroughly with water. Recrystallization 
from petroleum ether (60-70) yielded 4.37 g (95%) of N-stearoyl 
phenylserine ethyl ester, m.p. 55-56°. 
Thionyl chloride (4 ml) was added dropwise to a solution of 
N-stearoyl phenylserine ethyl ester (3.325 g) in chloroform (4 ml) at 
0° and left to stand overnight. The solvents were removed under 
reduced pressure at room temperature, the residue dissolved in diethyl 
ether, washed with sodium carbonate solution, and the solvent removed 
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to yield 3.3 g of material. This was applied to a column of silicic 
acid (100 g), and ethyl-(N-stearoy1-3-phenyl-3-chloro-2-amino) 
propanoate eluted with chloroform in 70-80% yield (m.p. 75-76'). 
(v) N-stearoyl t-phenylserinol; reaction with SOC1 2 
The reaction conditions for the preparation of N-stearoyl t-
phenylserinol were the same as those for the preparation of N-stearoyl 
phenylserine ethyl ester. The product was obtained in 79% yield, and 
when recrystallized from methanol melted at 78-80° (the p-nitro analogue 
melts at 92_940129). 
The products resulting from the reaction of this compound with . 
thionyl chloride at 0° were numerous. IR spectroscopy identified some 
of the minor products as amides and esters containing a chlorine group 
on the carbon atom in the a-position to the phenyl group. The major 
product, isolated in 40-50% yield by silicic acid column chromatography, 
was 2-heptadecy1-4-(1-phenyl-1-chloromethyl)-2-oxazoline. This compound 
was non-reactive towards silver carbonate and hot sodium hydroxide 
solution, remained a colourless oil at 0°, and showed strong absorption 
at 1665 cm
-1 
•(v C=N) in the IR spectrum. The NMR signals were clearly 
resolved, occurring at 2.75 T (for 5 aromatic protons), 3.1 T (for 1 
proton on the carbon containing the Cl), 3.8 T (for 2 protons in the 
5-position on the ring), 7.85 T (for 1 proton in the 4-position on the 
ring), and 8.75 and 9.1 T (for the aliphatic protons). 
N-isonicotinoyl phenylserinol  
Isonicotinoyl chloride hydrochloride was prepared by heating a 
solution of isonicotinic acid in thionyl chloride at 60 ° for 1 hour130 . 
The solvent was removed under reduced pressure, and the residue sublimed 
onto a cold finger at 1 mm Hg pressure. It melted at 157-160 ° (dec.); 
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after one recrystallization the m.p. rose to 164-165°, as reported 130 . 
Isonicotinoyl chloride hydrochloride (1.066 g, or 6 mmole) in N,N-
dimethylformamide (20 ml) was added with stirring to t-phenylserinol 
(1,000 g, or 6 mmole) in N,N-dimethylformamide (20 ml) and triethylamine 
(2 m1). After standing overnight the triethylamine hydrochloride was 
removed by filtration, the solvent removed under reduced pressure, and 
the residue dissolved in hot chloroform. The free isonicotinic acid 
was removed by filtration, and the chloroform cooled to yield 1.55 g 
(95%) of N-isonicotinoyl t-phenylserinol, m.p. 145-146° (white flakes). 
Recrystallization from 2% ethanol in chloroform yielded the same 
compound, which gave one spot on TLC plates (Analysis: C, 65.6; 
H, 5.9; N, 10.1%. Calcd. for C 1 01603 N 2 : C, 66.1; H, 5.9; N, 10.3%). 
The compound was soluble in water and alcohols, sparingly soluble 
in hot chloroform, and insoluble in ether and hydrocarbons. Its IR 
spectrum showed absorption at 3390 cm  OH), 3300 cm  NH), 
-1  
3230 cm and 1630 cm (v C=0), and 1540 cm (6 NH). The UV spectrum 
gave peaks at 211 mw (c max = 18100) and 252 Mp (E max = 7200) for the 
pyridyl and phenyl groups. 
(vii) Reaction of a natural ceramide mixture with SOC1 2 
The action of thionyl chloride at 0° on NFA ceramides produced a 
mixture of (3-ch1oroamides, (3-ch1orooxazolines (v C=N, 1660 cm
-1
), and 
other produc's. 
(b) Long-chain (3-hydroxyamino acids  
(i) Copper II-Schiff base complexes  
N-salicylideneglycinataquo copper II dihydrate was prepared from 
salicylaldehyde, glycine, and cupric acetate, as described
131
. After 
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recrystallization from water-ethanol mixtures, dark green crystals 
were obtained. 
N-pyruvylideneglycinatoaquo copper II dihydrate was prepared 
essentially as described
120
, with the exception that the final product 
was recrystallized from water. It decomposed at 206° (reported, 195'). 
N-pyruvylideneglycinatopyridine copper II trihydrate was prepared 
by treating the above compound with pyridine in dry acetone
120
. The 
product decomposed at 142° (reported, 133'). 
(ii) a-amino--hydroxystearic acid  
The preparation of a long-chain hydroxyamino acid proved to be 
difficult owing to the insolubility of the aldehyde in the aqueous-
methanolic media necessary to dissolve the complex. Several 
variations of the method described here were tried, but yields were 
poor (5% or less). 
To a mixture of N-pyruvylideneglycinatoaquo copper II dihydrate 
(1.3 g, or 5 mole) and hexadecanal 132 (2.4 g, or 10 mmole) in 
methanol (40 ml) and diethyl ether (5 ml), were added 1 N sodium 
methoxide (7 m1). The mixture was stirred under nitrogen overnight 
at 35°. After this time, 3 N acetic acid (5 ml), water (50 ml), and 
diethyl ether (100 ml) were added, and the products partitioned into 
the ether. Evidence for the presence of a-amino--hydroxystearic 
acid was found in its IR spectrum, its positive reaction with ninhydrir 
and the chromatographic behaviour of its DNP derivative. The latter 
experiment indicated the presence of e- and t-isomers, since two spots 
were found on TLC plates impregnated with borate (R f values, 0.63 and 
0.75; developing solvent, chloroform-methanol-water (65:25:4)). 
An equally unsuccessful attempt to prepare the above compound 
was made using N-pyruvylideneglycinatopyridine copper II trihydrate. 
67 
This complex was found to be more soluble in the methanol-ether 
mixtures used for the reaction, but yields were still low owing to the 
insolubility of the aldehyde. 
(iii) a-amino-e.-hydroxy-trans-4-hexenoic acid  
N-pyruvylideneglycinatoaquo copper II dihydrate (2.6 g, 10 mmole) 
and crotonaldehyde (2.1 g, 30 mmole) were dissolved in water (50 ml), 
and sodium hydroxide added to bring the pH up to 9.5. The solution 
was stirred at room temperature for four hours, after which the pH 
was adjusted to 4.5 with 3 N acetic acid. It was then poured onto a 
column (3 cm x 10 cm) of Amberlite IR-120 (H form). The column was 
washed with distilled water (1 0, and the amino acids eluted with 2‘11 
aqueous ammonia (1 t). The solvent was removed to produce a 
stereoisomeric mixture of DL-a-amino-f3-hydroxy-trans-4-hexenoic acids 
(impure), m.p. 200° (dec.). The mixture had similar chromatographic 
properties as the DL-a-amino÷.hydroxy-4-hexynoic acids 133 . 
(c) Oxazolines and their degradation products from ,...hydroxyamino  
acids  
Phenylserine ethyl ester, or threonine ethyl ester 134 , were 
condensed with aliphatic or aromatic imidic acid ester hydrochlorides 
to yield oxazolines. Their lithium aluminium hydride reduction 
products gave 0-acyl derivatives on mild iwdrolysis; further treatment 
with alkali afforded N-acyl derivatives. The accompanying tables 
(Tables 3,4) give some properties of the compounds prepared. 
(i) Imidic acid ester hydrochlorides135 
Lauronitrile (18.1 g, or 0.1 mmole) and absolute ethanol (4.5 g, 
or 0.1 mole) were treated with hydrogen chloride (4.4 g, or 0.12 mole) 
68 
at room temperature for three hours. Dry ether (100 ml) was added, 
and the mixture left at 00 overnight to yield 18 g of ethyliminolaurate 
hydrochloride, m.p. 79-80° (dec.). Similarly prepared were ethylimino- 
myristate hydrochloride, m.p. 82-84° (dec.), ethyliminostearate 
hydrochloride, m.p. 87-89° (dec.), and ethyliminobenzoate hydrochloride, 
m.p. 114-115° (dec.); the latter was prepared at 0°. 
2,5-dialky1-4-carboethoxy-2-oxazolines  
- 
The following method is typical. Phenylserine ethyl ester 
(0.02 mole) and ethyliminolaurate hydrochloride (0.02 mole) were 
dissolved in anhydrous chloroform (50 ml) and refluxed for one hour. 
The ammonium chloride was washed out with water, or removed by 
centrifuging at 15000 r.p.m., and the chloroform removed at 40° under 
reduced pressure. The product was used without purification for 
reduction of the carboethoxy group, as follows. 
(iii) 2,5-dialky1-4-hydroxymethy1-2-oxazolines  
A stirred suspension of lithium aluminium hydride (0.6 g) in dry 
ether (50 ml) was boiled for 10 min and cooled in ice. To this was 
added, dropwise, a solution of an ester (0.015 mole) in dry ether 
(50 m1). The mixture was stirred for a further 10 minutes at room 
temperature, refluxed for 10 minutes, cooled, and the excess reagent 
hydrolysed by adding water (1 ml) and 10% sodium hydroxide (2 ml) 
dropwise. The lithium and aluminium salts were removed by 
filtration, and the ether removed under reduced pressure. The 
residual oil was dissolved in hot ether or hexane, filtered, cooled 
in a mixture of ice and salt, and the crystals collected. 
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(iv) 1-0-acyl-phenylserinol hydrochlorides  
A solution of the oxazoline from (iii) in 1 N methanolic 
hydrochloric acid was left at room temperature overnight. The solvent 
was removed at room temperature under reduced pressure, and the 
residue recrystallized from an appropriate solvent. 
-acyl-phenylserinols  
A solution of the 0-acyl derivative from (iv) in methanol was 
treated with dilute ammonia carefully to pH 5-6. Chloroform was 
added, the ammonium chloride washed out with water, and the solvent 
removed at room temperature under reduced pressure to yield the N-acyl 
derivatives; recrystallization from chloroform-hexane gave a pure 
product. The free 1-0-acyl phenylserinols were not stable enough 
for their isolation under these conditions; 0-benzoyl threonines 
have been isolated, however
116
. 	Storage of the hydrochlorides over 
potassium hydroxide in a vacuum did not liberate the free 0-acyl 
derivatives. 
(vi) Configuration of the oxazolines
117 
2-Undecy1-5-pheny1-4-carboethoxy72-oxazoline (1.50 g) was 
hydrolysed to the 0-acyl derivative by treatment for 18 hours at room 
temperature with 0.5 N methanolic hydrochloric acid (25 m1). The 
solution was neutralized with 2 N sodium hydroxide, a further 5 ml of 
this reagent added, and refluxed for 30 minutes. After cooling, 2 N 
hydrochloric acid (10 ml) and ice-water (100 ml) were added, the 
precipitate collected, dried over KOH, and recrystallized twice from 
chloroform-hexane (1:6). N-undecanoyl phenylserine was obtained in 
90% yield (1.31 g), m.p. 112-113 ° . The IR spectrum showed absorption 
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at 2310 cm (v N-H), 1700 cm, 1725 cm (v C=0 for the acid), 
-1 -1 
1643 cm (v C=0 for the amide), and 1523 cm (6 N-H). Analysis by 
TLC on plates impregnated with borate revealed the presence of a 
single compound (developing solvent, chloroform-methanol-water 
(65:25:4); R f value, 0.60). 
2-Undecy1-5-pheny1-4-carboethoxy-2-oxazoline (1.50 g) was treated 
with sodium ethoxide (2.5 g) in dry ethanol (25 m1). After 10 minutes 
water (5 ml) was added, the solution refluxed for 15 minutes, then 
acidified with hydrochloric acid to 0.5 N and allowed to stand overnight 
at room temperature. The N-acyl compound was formed by adding 10% 
sodium hydroxide to pH 11, and acidifying with dilute hydrochloric acid. 
Recrystallization from chloroform-hexane (1:6) afforded crystals in 
85% yield (1.24 g), m.p. 112-113°. Its IR spectrum and chromatographic 
properties were identical to those of the product obtained from direct 
acid hydrolysis, indicating the trans-configuration for the oxazolines. 
(d) Oxazolines and their degradation products from sphingoids  
Sphingoids were condensed with aliphatic imidic acid ester 
hydrochlorides to yield oxazolines. A reaction scheme illustrating 
some of their degradation products has been described (Fig. 9, p. 59). 
All compounds prepared are tabulated (Tables 3,4). 
(i) Oxazolines  
A solution of a sphingoid (1 mole, or 300 mg) and imidic acid 
ester hydrochloride (1 mole) in dry chloroform (4 ml) was refluxed 
for 3 hours under nitrogen, cooled, and the liberated ammonium 
chloride washed out with water. The chloroform was removed under 
reduced pressure at room temperature, and the oxazoline purified 
either by recrystallization from ethanol, or by preparative TLC 
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(developing solvent, 2% CH 3OH in CHC1 3 ). In general the yields were 
good (60-80%), and fine white crystals were obtained from pure 
starting materials. 
( ii) 0-acyl sphingoids  
A solution of the sphingoid-oxazoline (0.4 mmole) in chloroform 
(10 ml) was acidified with 0.1 N sulphuric acid (0.22 mmole), and 
allowed to stand for three days at room temperature under nitrogen. 
After this time, the excess acid was washed out by adding methanol 
(2.8 ml) and water (4 ml), and shaking. The lower chloroform layer 
was withdrawn, evaporated to dryness at room temperature under 
reduced pressure, and the residue recrystallized from methanol to 
yield 0-acyl sphingoid sulphates. 
The acid salt (0.25 mole) in chloroform (10 ml) was treated with 
0.05 N methanolic ammonia (5.2 ml, or 0.26 mmole) at 0°. Water (4 ml) 
was added, and the free esters partitioned into the chloroform. The 
solvent was removed at room temperature under reduced pressure, and 
the ester recrystallized from methanol. 
N-acyl sphingoids  
The 0-acyl isomers in chloroform were treated with methanolic 
sodium hydroxide. After acidifying and washing out the salt and free 
acid, the residue was purified by TLC, and recrystallized from methanol 
or ethanol to yield pure ceramides. 
Table 3  
Oxazolines derived from phenylserine, threonine, or sphingoids a 
No. Oxazoline substituents 
R2 	R4 	R5 
M.p. ° Yield % IR data 
(Nujol) 
Formulae C % 
Found 
(Calcd.) 
H % 
Found 
(Calcd.) 
N % 
Found 
(Calcd.) 
1 Und cEy Ph 10-11 100 1660 (v C=N) C23H3503N 73.7 9.8 4.1 
1735 (v C=0) (73.9) (9.4) (3.8) 
2c Heptad cEy Ph 42-43 100 1660 (v C=N) 
3b,c Ph cEy Ph • <0 100 1642 (v C=N) 
1735 (v C=0) 
4 c Und cEy Me -7 100 1660 (v C=N) 
1740 (v C=0) 
5b,c Ph cEy Me <0 100 1645 (v C=N) 
6
c 
Heptad cEy Me 28 100 1660 (v C=N) 
7 Und hMe Ph 49.5 85 1660 (v C=N) C21 1-12302N 76.2 10.0 4.1 
3230 (v O-H) (76.1) (10.0) (4.2) 
8 Ph hMe Ph 160 82 1644 (v C=N) C 1 01502N 76.1 6.0 5.6 
3155 (v 0-H) (75.9) (6.0) (5.5) 
Table 3 contd. 
10 
Und hMe Me 
Ph hMe Ph 
42.5 
87 
82 
86 
1660(v. C=N) 
3250 (v 0-H) 
1642 (v C=N) 
3170 (v 0-H) 
C16H31 02N 
C10H1302N 
71.3 
(71.3) 
69.0 
(69.1) 
11.4 
(11.6) 
7.0 
(6.9) 
5.3 
(5.2) 
7.6 
(7.3) 
11 Trid lh-Hexad
A2 	
H 89-90 68 1665 (v C=N) C32H 61 02N 78.6 12.3 2.6 
3150 (v 0-H) (78.2) (12.5) (2.8) 
12 Trid lh-Hexad H 74-75 7 1665 (v C=N) C32H63 0 2N 77.2 12.8 2.6 
3230 (v 0-H) (77.8) (12.9) (2.8) 
13 Trid hMe Pentad 47-49 74 1655 (v C=N) C32H6302N 77.7 12.8 2.7 
3245 (v 0-H) (77.8) (12.9) (2.8) 
, 
a) All compounds are new. b) could not be induced to crystallize. c) have not been sent for microanalysis. 
Table 4  
Esters and amides derived from phenylserine and sphingoidsa 
No. Compound Name M.p. ° Yield % IR data 
(Nujol) 
Formulae C % 
Found 
(Calcd.) 
H % 
Found 
(Calcd.) 
N % 
Found 
(Calcd.) 
..b 
1 1-0-undecanoyl phenylserinol, 134-5 92 1730 (v C=0) C 21 H3603NC1 65.3 9.4 3.9 
HC1 salt (dec.) 3360 (v 0-H) (65.4) (9.4) (3.6) 
2c 1-0-benzoyl phenylserinol, 177-9 95 1725 (v C=0) C16H1803 NC1 62.1 5.9 4.5 
HC1 salt (dec.) 3400 (v 0-H) (62.4) (5.9) (4.6) 
3 N-undecanoyl phenylserinol 96-97 100 1635 (v C=0) 9 H 03 N 72.2 , 10.1 4.0 
1525 (6 N-H) ' (72.5) : (10.2) (3.9) 
4d N-benzoyl phenylserinol 161.5 93 1625 (v C=0) C 16H 17 03N 69.4 6.4 5.3 
1545 (6 N-H) (70.8) (6.3) (5.2) 
5 1-0-14:0-De-d18:1, H 2SO4 salt 122 82 1740 (v C=0) C32H640 5NS 68.8 11.7 2.6 
(dec.) (68.8) (11.5) (2.5) 
6 1-0-14:0-De-d18:1 95 68 1720 (v C=0) C32H6303 N 76.0 12.2 2.7 
(75.4) (12.5) (2.8) 
7 1-0-14:0-De-d18:0, H 2SO4 salt 130-2 78 1740 (v C=0) C32 H660 5NS 67.1 11.8 2.4 
(dec.) (68.5) (11.9) (2.5) 
8 1-0-14:0-De-d18:0 96-99 64 1720 (v C=0) C32 H6503N 74.9 12.6 2.5 
(75.1) (12.8) (2.7) 
Table 4 contd. 
h 9 	3-0-14:0-DLt-d18:0, H 2SO4 salt 166-9 (dec.) 
75 1740 (v C=0) 
10 h 3-0-14:0-DLt-d18:0 89-91 63 1720 (v C=0) 
11 e,h 14:0-De-d18:1 94-95 64 1640 (v C=0) 1545 Co N-H) 
12f 14:0-DLe-d18:0 100-1 , 68 1640 (v C=0) 1550 (6 N-H) 
13 h 14:0-DLt-d18:0 93-94 58 1610 (v C=0) 1550 	(6 N-H) 
/ 
14g 	24:0-DLt-d18:1 93-94 72 1610 (v C=0) C42 H8303 N 76.9 	/ 13.3 2.1 1545 (6 N-H) (77.0' (12.9) (2.2) 
15g 	24:0-DLt-d18:0 92-93 65 1610 (v C=0) CA2H8503 N 77.2 12.8 2.0 1550 	(6 N-H) -r (77.3) (13.1) (2.1) 
a)All compounds, with the exception of No. 12, are new; 
b)Cl% found, 9.2 (calcd., 9.5); c) Cl% found, 11.5 (calcd., 12.0); dl recrystallized many times; e) reported m.p. for 14:0-DLe-d18:1, 86_87136;  f) reported m.p., 103_418 ; g) prepared by method of HammarstrOm36 ; z 
the m.p. of its e-isomer was thesame as that reported 137 ; h) not prepared in sufficient quantity for microanalysis. 
76 
CHAPTER 3  
STEREOCHEMICAL STUDIES OF SPHINGOID DERIVATIVES 
Other authors have separated diastereoisomers of psychosines 138 
and sphingosylphosphorylcholines
13 
by TLC on plain silica gel, and of 
DNP derivatives of sphingoids
31 
and polyhydroxy fatty acids
139 
on 
silica gel impregnated with borate. Diastereoisomeric N-acetyl 
sphingoids have been separated by GLC
84
. It is now shown that the 
modifications described in Chapter 1 (pp.23and 36) for these methods 
may be used for similar chromatographic separations of aLy1 sphingoids. 
The results may be used to obtain evidence for the existence of 
natural diastereoisomeric ceramides. This is also the place to 
consider possible stereochemical changes in acyl sphingoids and 
related oxazolines under normal or adverse conditions, and 
spectroscopic differences between isomers. 
1. TLC of isomeric acyl sphingoids and sphingoid-oxazolines  
(a) Diastereoisomeric ceramides  
Ceramides were synthesized essentially by a known method 3 , that 
of condensing the sphingoid and fatty acid in the presence of a 
carbodiimide. The byproducts of the synthesis (mainly N-acylureas
140
) 
were removed by preparative TLC, and the ceramides recrystallized from 
methanol. Most of the ceramides prepared for TLC (or GLC) analysis, 
including all of those derived from t-sphingoids or L-2-hydroxy fatty 
acids, were new compounds so far as is known; some were prepared in 
quantities large enough for microanalysis (p.75). 
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The separation of diastereoisomeric ceramides on TLC plates is 
illustrated in Figs. 1 to 5, and their R f values are listed in 
Table 1. It may be seen that diastereoisomeric NFA ceramides do not 
separate on a plain TLC plate (Fig. 1). On a plate impregnated 
with borate (Fig. 2), NFA ceramides derived from either e-d18:1 
(lane 2), t-d18:1 (lane 3), or t-d18:0 (lane 5), are retarded. The 
former effect has been observed befor-e71 . The latter effect may be 
ascribed to the complex formed between the borate ion and the two 
hydroxy groups of the sphingoid. The partial separation observed 
between diastereoisomers derived from d18:1 (lanes 2 and 3) indicates 
that the borate ion may complex with the 3-hydroxy group and the 
double bond. A minor component in lane 6 was left unidentified by 
others using similar standards
137
. Its persistent similarity to the 
product of lane 5 under diverse chromatographic conditions suggests 
that it is also a t-ceramide. 
HFA ceramides derived from a DLe- orDLt-sphingoid (d18:1 or d18:0), 
or a mixture of these, and a racemic 2-hydroxy fatty acid, gave two 
spots on freshly activated plain TLC plates (Fig. 3, lanes 2 and 3). 
Similar results have been obtained by others for diastereoisomeric 
HFA ceramides derived from De-d18:1
36
; the upper and lower spots 
observed here may be ascribed to HFA ceramides derived from L- and D-
hydroxy fatty acids respectively. When representatives of these 
ceramide classes were prepared from a diastereoisomeric mixture of 
d18:1 or d18:0, a partial separation on undctivated TLC plates was 
observed (not illustrated). On plates impregnated with borate, the 
e- and t-ceramides, with either L- or D-hydroxy fatty acids, were 
completely separated from each other (Figs. 4 and 5). These results 
differ from those of NFA ceramides in that e- and t-diastereoisomers 
derived from d18:1 are separated. This behaviour could be explained 
by a borate complex formed between the hydroxy group of the fatty acid 
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Analysis of diastereoisomeric ceramides 
Edwin E George and John B Polya 
Chemistry Department, University of Tasmania, Hobart, 7000, Australia 
Determination of the most important sphingolipids 
(particularly sphingomyelins and cerebrosides) is carried out by 
their hydrolysis to free ceramides (N-acyl sphingoids l ) which are 
then subjected to chromatography, usually after derivatisation. 
Such a procedure is inadequate when interest centres on the 
presence of free ceramides that are of diagnostic significance in 
food chemistry' or clinical biochemistry' as minor constituents 
of some natural fats and oils. A simple method of t .1.c. suitable 
for the analysis of sphingomyelins and cerebrosides ° does not 
separate free ceramides from the latter or requires additional 
operations' that make routine assays impracticable and fail to 
distinguish between different classes of ceramides. 
A convenient method of t.l.c. employs silica gel G (Merck) 
and a mixture of chloroform/carbon tetrachloride/methanol/ 
water, 50:50:12:0-5 v/v (eluting agent A). Ceramides in the 
region of R 1 0-28-0-56 are well separated from the much slower  
cerebrosides and faster cholesterol bands, and sub-
fractionation of structurally or stereochemically different 
classes of ceramides is satisfactory for the purposes of 
quantitative analysis of preparative t .1.c. 
Three types of interfering lipid have been found. Free fatty 
acids can be eliminated either by a lcm thick bar -; — produced at 
the bottom of the plate by spraying it with a 10 per cent solution 
o f sodium carbonate or more satisfactorily by replacing water in 
the eluting agent by 15N ammonia. ' Neither of these procedures 
affects the R fof neutral lipids. Monoglycerides have the same R, 
values as the relatively rare ceramides derived from a-hydroxy-
acids, and can be recognised by colour tests for esters' or vicirial 
diols,' estimation of ester groups' or infrared spectroscopy. 
In some commercial ceramides prepared by oxidative 
degradation of cerebrosides followed by hydrolysis, 9 on 
encounters `polyols' identified as CI-13(CH2)12CH 
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Table 2 Retention times of diastereiosomeric ceramides,°relative to N-stearoyl erythro-sphinganine 
Ceramides derived from sphingenine 	 Ceramides derived from sphinganine 
N-acyl-b 	unsubstituted acid 	 hydroxy acids 	 unsubstituted acid 	 hydroxy acids 
e 	I 	L'e 	L 't 	D'e 	D't 
	
L'e 	L't 	D'e 	D't 
14:0 	0-47 	0•43 • 
16:0 0.66 	0-60 . 	0-68 
18:0 , 	0.93 	0-85 	0-96 
20:0 1-35 1-24 1-35 
22:0 	1-99 	1-82 	2-00 
24:0 2•90 	2.66 	2-86 
24:1 
26:0 	4-22 	 4-14 
0.47 	 0-50 	0-45 
0-66 	0-68 	0-56 	0-70 	0-63 	0-68 
0-96 	0.79 1•00 	0.89 	0.96 
1-35 1.14 	. 1-45 1.29 1-37 
2.00 	1.68 	2-14 	190 	2.03 
2-86 	2-43 3-12 	2.78 2.90 
	
3.07 2.74 
4.14 	3.55 	 4-20 
0.63 0.68 	0-56 
0-96 0-79 
1-37 	1-14 
2.03 1-67 
2-90 	2-42 
4.20 	3-51 
or D and e or t indicate the configuration of the 2-hydroxy fatty acid and sphingoid, respectively; 
bnumber of C atoms and unsaturation are indicated • 
=CH- CHOH - CH(NHCOR)-CH 20-CH(CH 2OH)-OCH 
(CH 2OH)2  by infrared and mass spectroscopy and conversion 
into ceramides on prolonged hydrolysis. In many cases (e.g. 
study of synthetic ceramides) monoglycerides and polyols may 
be ignored; otherwise they may be separated from ceramides by 
two-dimensional chromatography first with eluting agent A, 
then ether/acetone/ 15N ammonia, 80:20:2 v/v.' 
Stereochemical separation of various sphingoid derivatives 
by t.l.c. on silica gel l" or silica gel impregnated with borate." 
has been extended to ceramides available as commercial 
samples or prepared from brain".'or milk"or by synthesis.' 
Free threo ceramides move slower than erythro 
diastereoisomers. Although separation of diastereoisomeric 
ceramides derived from unsubstituted fatty acids and 
unsaturated s hingoids is incomplete (presumably owing to the 
group), 2-hydroxy-acid. derivatives of both saturated and 
unsaturated sphingoids are easily separated. It is known that 
erythro ceramides derived from L-acids move faster than those 
derived from p-acids ,12 now it is found that the same rule applies 
to threo ceramides and that D-erythro moves faster than L-threo. 
R 1  values on plain and borate-treated t.l.c. plates developed with 
chloro form containing 8 per cent v/v methanol (eluting agent B) 
shown in Table 1 are given relative to the Rf (0-50) of racemic 
N-stearoyl-erythro-sphinganine. 
Separation of diastereoisomeric sphingoids as N-acetyl 
derivatives by g.l.c. 18  can be extended to ceramides. Retention 
times relative to N-stearoyl erythro-sphinganine in the range on 
a column (3.3mm by 3m, glass) containing 1 per cent GE SE-30 
(GC grade) plus 1 per cent 0 V-17 on 100-120 mesh Gas Chrom Q 
are shown in Table 2. It is-seen that threo compounds emerge 
before erythro isomers. 
The authors thank the Commonwealth Department of 
Education for a postgraduate grant (to E.E.G.). 
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Table I R f  values of ceram ides relatively to N-stearoyl.erythro-sphinganine 
on plain t.l.c. plates or plates impregnated with 10 per cent w/w borate, 
developed with 8 per cent CH 3OH in CHCI 3. 
Ceramide moieties ° 	 Relative R f values on 
N-acyl 	racemic sphingoid plain plates borate plates 
1-12 
1.10 
1-12 
1.10 
0-92 
0-90 
0-84 
0-78 
1.12 
0.86 
0.72 
0.68 
0.92 0-92 References 
0-90 0-74 
I .02 0-72 IUPAC-1UB Comm. of Biochemical 'Nomenclature: 'The nomenclature 
0-76 0.60 of lipids', J. Lipid Res., 1978, 19,114 
1-00 0-58 2 	Polya, J. B., Dairymen's Digest, 1973, 1, 9 
0-70 0-36 3 	Polya, J. B. & Parsons, R. S., Med. J. Aust., 1973, 1, 873 
1.00 1.00 4 	Gloster, J. & Fletcher, R. F., Clin. Chim. Ada, 1966, 13, 235 
0-74 0-74 5 	Lowenstein, J. M. (Ed.) in `Methods in encymology', 1969, 15, p 308 
0-98 0.58 6 Skidmore, W. D. & Entenman, C., J. Lipid Res., 1962, 3, 471 
0-70 0-36 7 Shaw, N., Biochim. Biophys. Acta., 1968, 164,435 
0.90 0.64 8 	Renkonen, 0., ibid. 1961, 54, 361 
0-64 0-54 9 Carter, H. E., Roth fus, J. A. & Gigg, R., J. Lipid Res., 1961, 2, 228 
0.84 0-50 1 ° Fujino, Y. & Negishi, T., Biuochim. Biophys. Ada., 1968, 152, 428 
0.56 0.28 II lwamori, M., Moser, H. W. & Kishimoto, Y., J. Lipid Res., 1975, 16, 332 
0-90 0.88 12 Karlsson, K. A. & Pascher, 1., ibid. 1971, 12, 466 
0.64 0.66 13 Karlsson,.K. A., Chem. Phys. Lipids, 1970, 5, 6 
0.84 0-50 14 Carter, H. E:, Haines, W. J., Ledyard, W. E. & Norris, W. P., J. Biol. 
0-56 0-28 Chem., 1947, 169, 77 
15 Morrison, W. R. in Gunstone, F. D., 'Topics in lipid chemistry', 1970, 1, 51 
16  George, E. E., M.Sc. Qual. Thesis, University of Tasmania, 1974 
17 Hammarstrom, S., J. Lipid Res., 1971, 12, 760 
18 Carter, H. E. & Gayer, R. C., ibid, 1967, 8, 391 
24:0 	e-18:1 
24:0 t-18:1 
24:0 	e-I8:0 
24:0 t-I8:0 
14:0 	e-18:1 
14:0 1-18:1 
14:0 	e-18:0 
14:0 1-18:0 
L-h 26:0 	e-18:1 
o-h 26:0 e-I8:1 
L-h 26:0 	(-18:1 
o-h 26:0 t-18:1 
L-h 26:0 	e-I8:0 
o-h 26:0 e- 18:0 
L.-h26:0 	(-18:0 
o-h 26:0 t-18:0 
L-h 16:0 	e-I8:1 
o-h 16:0 e-18:1 
L.-h 16:0 	1-18:1 
o-h 16:0 (-18:1 
L-h 16:0 	e-I8:0 
o-h 16:0 e-18:0 
L-h 16:0 	1-18:0 
o-h 16:0 1-18:0 
e =erythro t = threo h = ci-hydroxy; 
b absolute value of R I.= 0-50 
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Fig. 1. TLC plate illustrating the separation of isomeric 
ceramides. Developing solvent, chloroform-carbon tetrachloride- 
methanol-water (50:50:12:0.5). 1, natural ceramides from brain 
sphingomyelin; 2, 24:0-DLe-d18:1 (upper spot) and 14:0-De-d18:1 
(lower spot); 3, 24:0-DLt-d18:1; 4, 24:0-DLe-d18:0 (upper spot) and 
14:0-DLe-d18:0 (lower spot); 5, 24:0-DLt-d18:0 (upper spot) and 
14:0-DLt-d18:0 (lower spot); 6, standard ceramides, 24:0-DLe-d18:0 
(upper spot) and 16:0-DLe-d18:0 (lower spot). 
Fig. 2. TLC plate illustrating the separation of diastereoisomeric 
NFA ceramides; the silica gel is impregnated with borate (10% w/w). 
Developing solvent, chloroform-carbon tetrachloride-methanol-water 
(50:50:12:0.5). 1, natural ceramides from brain sphingomyelin; 
2, 24:0-DLe-d18:1; 3, 24:0-DLt-d18:1; 4, 24:0-DLe-d18:0; 
5, 24:0-DLt-d18:0; 6, standard ceramide, 24:0-DLe-d18:0. 
Fig. 3. TLC plate illustrating the separation of diastereoisomeric 
HFA ceramides. Developing solvent, chloroform-methanol (92:8). 
1, natural mixture of NFA ceramides (upper spot) and HFA ceramides 
(lower spot); 2, L-h18:0-DL(e+t)-d18:1 (upper spot)  and D-h18:0- 
DL(e+t)-d18:1 (lower spot); 3, L-h18:0-DL(e+t)-d18:0 (upper spot) and 
D-h18:0-DL(e+t)-d18:0 (lower spot). 
Fig. 4. TLC plate illustrating mixtures of diastereoisomeric 
;;FA ceramides; the silica gel is impregnated with borate (10%, w/w). 
Developing solvent, chloroform-methanol (85:15). 1, natural mixture 
of HFA ceramides; 2, DL-h24:0-DL(e+t)-d18:1; 3, DL-h18:0-DL(e+t)- 
d18:1; 4, DL-h26:0-DL(e+t)-d18:0. — 
Fig. 5. TLC plate illustrating the ceramides which have been 
isolated from a diastereoisomeric mixture and recrystallized; the 
silica gel is impregnated with borate (10%, WM. 	Developing 
solvent, chloroform-methanol (85:15). 1, DL-h16:0-DL(e+t)-d18:°; 
2, L-h16:0-DLe-d18:0; 3, L-h16:0-DLt-d18:0; 4, D-h16:0-DLe-d18:0; 
5, D-h16:0-DLI--d18:0. 
Fig. 6. TLC plate illustrating the relative chromatographic 
mobilities of isomeric acyl sphingoids; the silica gel  is impregnated 
with borate (10%, w/w). Developing solvent, chloroform-methanol (92:8). 
1, 14:0-De-d18:1 (the faint spot below is probably a trace of the 
t-isomer); 2, 1-0-14:0-De-d18:1 (upper spot) and 3-0-14:0-De-d18:1 
power spot); 3, 1-0-14:0-DLe-d18:0 (upper spot) and 3-0-14:0-DLe-d18:0 
(lower spot); 4, 3-0-14:0-DLt-d18:0; 5, 14:0-DLe-d18:0 (upper spot) 
and 14:0-DLt-d18:0 (lower spot). 
81 
Table 1  
Rf values of ceramides and 0-acyl sphingoids, relative to 18:0- 
DLe-d18:0, on plain TLC plates (column A), or plates impregnated with 
10% w/w borate (column 8). For plates developed with 8% CH 3OH in 
CHC1 3 , 18:0-DLeTd18:0 moves to Rf 0.50. 
Compound name R.4, values 
A 
24:0-DLe-d18:1 1.12 0.84 
24:0-DLt-d18:1 1.10 0.78 
24:0-DLe-d18:0 1.12 1.12 
24:0-DLt-d18:0 1.10 0.86 
14:0-DLe-d18:1 0.92 0.72 
14:0-DLt-d18:1 0.90 0.68 
14:0-DLe-d18:0 0.92 0.92 
14:0-DLt-d18:0 0.90 0.74 
1-0-14:0-DLe-d18:1 0.74 0.54 
3-0-14:0-DLe-d18:1 0.58 0.36 
1-0-14:0-DLe-d18:0 0.64 0.44 
3-0-14:0-DLe-d18:0 0.48 0.28 
3-0-14:0-DLt-d18:0 0.48 0.28 
L-h 26:0-DLe-d18:1 1.02 0.72 
D-h 26:0-DLe-d18:1 0.76 0.60 
L-h 26:0-DLt-d18:1 1.00 0.58 
D-h 26:0-DLt-d18:1 0.70 0.36 
L-h 26:0-DLe-d18:0 1.00 1.00 
D-h 26:0-DLe-d18:0 0.74 0.74 
L-h 26:0-DLt-d18:0 0.98 0.58 
D-h 26:0-DLt-d18:0 0.70 0.36 
L-h 16:0-DLe-d18:1 0.90 0.64 
D-h 16:0-DLe-d18:1 0.64 0.54 
L-h 16:0-DLt-d18:1 0.84 0.50 
D-h 16:0-DLt-d18:1 0.56 0.28 
L-h 16:0-DLe-d18:0 0.90 0.88 
D-h 16:0-DLe-d18:0 0.64 0.66 
L-h 16:0-DLt-d18:0 0.84 0.50 
D-h 16:0-DLt-d18:0 0.56 0.28 
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and the amide nitrogen
141
. Scale models based on the known 
structure of 24:0-t18:0
142 
showed that the hydroxy group of the - 
fatty acid and either of the hydroxy groups of the sphingoid were too 
distant for borate complex formation. 
These results show that the TLC detection of t-NFA ceramides in 
a diastereoisomeric mixture is difficult. On the other hand, the 
detection of t-HFA ceramides derived from 2-D-hydroxy fatty acids, 
and e- or t-HFA ceramides derived from 2-L-hydroxy fatty acids, is 
possible. In natural HFA ceramides neither t-sphingoids nor L-hydroxy 
fatty acids were detected by TLC (Figs. 3 and 4, lane 1 in each). 
The separation of ceramides derived from a DLe- or DLt-sphingoid, 
and a normal, 2-L-hydroxy or 2-D-hydroxy fatty acid, was attempted 
with TLC plates impregnated with borate and cellulose. The results 
were negative, but the mixtures may be resolved into their optical 
isomers by a recently published method
143 
which involves derivatisation 
with L(+) acetylmandeloyl chloride followed by TLC separation. 
(b) Isomeric 0-acyl sphingoids and related oxazolines  
The TLC separation of 0-acyl sphingoids from the parent ceramides 
on silica gel impregnated with borate is illustrated by Fig. 6. This 
kind of plate was found to give more effective separations than plain 
plates. Both 1-0-acyl sphingoids (major components, lanes 2 and 3) 
and 3-0-acyl sphingoids (major component, lane 4) are retarded by 
borate; the latter move the slowest since they contain a primary 
hydroxyl group. The 3-0-acyl derivatives of e-d18:1 and e-d18:0 
are represented by the slower moving minor spots of lane 2 and lane 3 
respectively. The Rf values of 0-acyl sphingoids are compared to 
those of ceramides in Table 1. 
Sphingoid-oxazolines are comparatively more non-polar than 
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acyl sphingoids; on TLC plates used to analyse ceramides, sphingoid-
oxazolines move close to the solvent front. A solvent system of 2% 
methanol in chloroform is more suitable for their analysis by TLC, 
and as illustrated (Fig. 14), isomers derived from e-d18:1, e-d18:0, 
and t-d18:0 are separated. Borate has no complexing effect on these. 
compounds, which is understandable since one of the hydroxy groups 
and the amide nitrogen of the parent ceramides are utilised in ring 
formation. 
2. GLC of diastereoisomeric ceramides  
Mixtures of ceramides, synthesised from diastereoisomeric 
sphingoids and normal or racemic 2-hydroxy acids , were analysed 
essentially by the GLC method described in Chapter 1 (p. ), with 
the exception that the helium flow rate was faster, 90 ml/minute. 
In general, t-ceramides emerged before e-ceramides. In the case of 
NFA ceramides derived from d18:1, the separation of diastereoisomers 
was incomplete, and a t-isomer was recognized as a minor component by 
a bump on the peak for the e-isomer (Fig. 7). Diastereoisomeric NFA 
ceramides derived from d18:0 were completely separated (not illustrated). 
In the case of HFA ceramides derived from d18:1, a t-isomer containing 
a D-2-hydroxy acid was completely separated from the other isomers 
(Fig. 8). The t-isomer containing an L-2-hydroxy acid was part of 
the peak for the e-isomers, though when chromatographed separately its 
retention time was slightly lower. Diastereoisomeric HFA ceramides 
derived from d18:0 gave similar results (not illustrated); however, 
the separation of these was slightly improved on a column of 3% SE-30 
on 100-120 mesh Gas Chrom Q, and the t-isomer containing an L-2- 
hydroxy acid was also distinguished (Fig. 9). 
The retention times for some of the synthetic ceramides 
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Fig. 7. GLC separation of synthetic NFA ceramides. The major peaks 
represent derivatives of e-d18:1, and the minor peaks represent 
derivatives of t-d18:1 (the fatty acid of each is indicated). A column 
(3m x 3.3mm) of—i% GE SE-30 plus 1% OV-17 on 100-120 mesh Gas Chrom Q, 
temperature 300°, and He flow rate 90 ml/min, was used. 
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Fig. 8. GLC separation of synthetic HFA ceramides. The minor peaks 
represent compounds derived from t-d18:1 and 2-D-hydroxy fatty acids, 
and the major peaks represent the isomers derived from e-d18:1 and 2-DL-
hydroxy fatty acids, plus t-d18:1 and 2-L-hydroxy fatty acids (the fatty 
acid of each is illustrated). The GLC conditions are given in Fig. 7. 
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Fig. 9. 	GLC separation of the isomers of DL-h16:0-rac-d18:0. 	A 
column (2m x 3mm) of 3% GE SE-30 on 100-120 mesh Gas Chrom Q, 
temperature 285°, and N2 flow rate 40 ml/min., was used. 
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Fig. 10. GLC separation of ceramides derived from brain NFA cerebrosides. 
The carbon chain lengths of the fatty acids are illustrated. GLC 
conditions are given in Fig. 7. 
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Fig. 11. GLC separation of ceramides derived from brain HFA cerebrosides. 
The carbon chain lengths of the fatty acids are illustrated. GLC 
conditions are given in Fig. 7. 
Table 2  
Retention times of diastereoisomeric ceramides, relative to 18:0-DLe-d18:0 
Fatty 
acid 
Ceramides derived from DL-d18:1 Ceramides derived from DL-d18:0 
NFA derivatives HFA derivatives
* 
NFA derivatives HFA derivatives
* 
e t L'e L't D'e D't e _ t L'e L't D'e D't 
14:0 0.47 0.43 0.47 0.50 0.45 
16:0 0.66 0.60 0.68 0.66 0.68 0.56 0.70 0.63 0.68 0.63 0.68 0.56 
18:0 0.93 0.85 0.96 0.96 0.79 1.00 0.89 0.96 
, 
0.96 0.79 
20:0 1.35 1.24 1.35 1.35 1.14 1.45 1.29 1.37 1.37 1.14 
22:0 1.99 1.82 2.00 2.00 1.68 2.14 1.90 2.03 2.03 1.67 
24:0 2.90 2.66 2.86 2.86 2.43 3.12 2.78 2.90 2.90 2.42 
24:1 3.07 2.74 
26:0 4.22 4.14 4.14 3.55 4.20 4.20 3.51 
L' or D' and eor t indicates the configuration of the 2-hydroxy fatty acid and sphingoid, respectively. _ _ 
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investigated, relative to 18:0-DLe-d18:0, are given in Table 2. The 
similarity of these values for either e-ceramides or t-ceramides 
containing the same number of carbon atoms is evident. Analysis of 
mixtures of ceramides of natural origin would require group separation 
followed by GLC-mass spectrometry. 
The methods for producing ceramides from other sphingolipids have 
not been investigated with regard to isomerisation. Thus natural 
brain ceramides, ceramides derived from brain sphingomyelin either 
enzymatically
58 
or by acetic acid hydrolysis
57
, and ceramides derived 
from brain cerebrosides by periodate oxidation followed by reduction 
and mild acid hydrolysis 61 , were analysed by this GLC method. The 
results for NFA ceramides and HFA ceramides derived from cerebrosides 
are illustrated (Figs. 10 and 11 respectively); t-ceramides were 
not detected. Alkaline hydrolysis of each ceramide fraction produced 
e-sphingoids only as determined by GLC (Ch. 1, P.36). 
3. Stereochemical changes during hydrolysis of sphingoid derivatives  
Acyl sphingoids and relat2d oxazolines derived from e-d18:1, 
• t-d18:1, e-d18:0, or t-d18:0 were subjected to hydrolysis with acid
98 
or strong alkali
61 
 , and the sphingoids analysed as DNP derivatives on 
TLC plates impregnated with borate
31
. Acid hydrolysis of N-acyl-, 
3-0-acyl-, and 2,3-substituted oxazoline derivatives of e-d18:1 
liberated the sphingoid unchanged, its diastereoisomer t-d18:1, 
dehydration products
144
, and 0-methyl derivatives
145,146
. All other 
sphingoid derivatives underwent acid hydrolysis with little degradation 
• or stereochemical changes to the sphingoids. Alkaline hydrolysis 
liberated only e-sphingoids in all cases, with the exception of the 
sphingoid-oxazolines which were not affected by this treatment. 
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4. 	Isomerisation of sphingoid-oxazolines in solution  
Pure sphingoid-oxazolines were stable when stored dry at 0 0 , but when 
dissolved in dry solvents such as alcohol, chloroform, or ether, the 
compounds began to isomerise. The presence of alkali and/or water 
did not change the rate of isomerisation appreciably. After several 
days of standing at room temperature, when no further change could be 
detected, mixtures of isomeric oxazolines in equilibrium were obtained. 
As illustrated (Figs. 12 and 13), the configurations of the sphingoids 
(determined by TLC of the DNP derivatives
31 
) did not change during 
isomerisation. The isomers most favoured were I (Fig. 12) and III 
(Fig. 13), derived from e- and t-sphingoids respectively; these were 
the principal compounds obtained from the condensation of the sphingoids 
with imidic acid ester hydrochlorides (Ch. 2, 13.70). The trans- 
oxazolines (III) seemed to be more stable than the cis-oxazolines (I), 
judging by the relative intensities of the TLC spots for each isomeric 
mixture (Fig. 14). The ratios I/II and III/IV, determined by weight 
after TLC separation, were approximately 70/30 and 95/5 respectively. 
During the isomerisation, and for several weeks after the reaction was 
complete, amides and esters of the parent compounds were not produced, 
as judged by TLC. The isomers could be separated by TLC (with some 
degradation to acyl sphingoids) and recrystallized without isomerisation. 
The processes of Figs. 12 and 13 resumed only when the separated 
isomers were .2dissolved. 
The oxazoline (II, R=CH3 (C112 ) 14 ), gave indefinite compounds when it 
was used by other workers
25 
for the synthesis of dihydrosphingomyelin; 
the instability observed here for this type of oxazoline may account for 
this. The synthesis was eventually carried out successfully with the 
2-phenyl analogue. 
92 
H H 
I 	1 7 	I 
R C C -CH 2 ., 	R-C C CH 2 OH 1 	1 1 2 	I OH N 0 	 0 N 
\C 
	
1 	 I 
11 
Fig. 12 
R 	 R 
s
I 
CI 
1\• \ 1- 
I 1 
	
I 
N 	0 	 H 	N 
• 	 I Il 	I 
R -C C -CH 	 .  R - C C--- CH 2 0H I 	I 1 	1 
OH H 	 0 H 
Fig. 13 
Figs. 12,13. Sphingoid-oxazolines in equilibrium in solution 
(derivatives of D-sphingoids only are illustrated for convenience). 
R = long-chain alkyl group. 
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Fig. 14. TLC plate illustrating isomerised sphingoid- 
oxazolines after standing in solution for several days; the intense 
spots are the more stable isomers. Developing solvent, chloroform- 
methanol (98:2). 1, oxazolines derived from e-d18:1 and 14:0 
(Rf 0.50, 0.33); 2, oxazolines derived from e-d18:0 and 14:0 
(Rf 0.56, 0.23); 3, oxazolines derived from t-d18:0 and 14:0 
(Rf 0.23, 0.56). 
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5. Spectroscopic analysis of sphingoid derivatives  
The detection of acyl sphingoids and sphingoid-oxazolines in 
ceramides, and the differentiation of isomeric sphingoid derivatives, 
was possible by the use of IR spectroscopy. Mass spectroscopy was of 
little use, due to the similarity in spectra. Apart from a few IR 
spectra for e-ceramides (in KBr discs) published by other workers 36 ' 137 
no data are available on diastereoisomers and related sphingoid 
derivatives. These are recorded in this section. 
(a) Diastereoisomeric acyl sphingoids  
The IR spectra (in Nujol) for 24:0-DLe-d18:0 and 24:0-DLt-d18:0 
(Figs. 15 and 16 respectively) are typical of those for other 
diastereoisomeric NFA ceramides. The main differences between the two 
are the positions of the C=0 stretch, the combined N-H and 0-H stretch, 
and the C-0 stretch. These differences may be attributed to the 
degree of intramolecular hydrogen bonding between the 3-hydroxy group 
of the sphingoid and the amide group. The main absorption bands for 
e-NFA ceramides (also for the natural derivatives) occur at 3260 cm
-1 
(v N-H and v 0-H), 3080 cm  II overtone of highly associated 
amides
147
), 1640 cm
-1 
(amide I band, primarily v C=0), 1550 cm
-1 
(amide II band, a mixture of 60% o N-H and 40% v C- N148), 1280 cm-1 
(amide III band, a mixture of 40% v C-N, 30% 5 N-H, and 20% v 
 
and 7190 cm
71 
to 1020 cm
-1 
(v C-0). For t-NFA ceramides, the 
-1 
respective frequencies are 3440 cm
-1 
plus 3350 cm 
-1
, 3080 cm (much 
-1 
decreased in intensity), 1610 cm
-1
, 1550 cm
-1
, 1310 cm 
-1 , and 1110 cm 
plus 1080 cm-1 . Diastereoisomers derived from d18:1 also absorbed at 
960 cm
-1 
(6 C-H for the trans-double bond). All these data were 
similar in both Nujol and KBr. In some spectra, including those of 
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both natural and synthetic ceramides, there was observed splitting of 
the amide I and amide II bands. The spectrum for 14:0-De-d18:1 
(Fig. 17), which was run under the same conditions as those reproduced 
in Figs. 15 and 16, shows absorption at 1643 cm -1 , 1615 cm-1 , 1566 cm-1 , 
and 1544 cm
-1
. 
Diastereoisomeric HFA ceramides could be distinguished by noting 
the positions of the amide I and amide II bands, the intensity of the 
amide II overtone, and the shape of the combined N-H and 0-H stretch. 
Apart from these differences the spectra were much the same. The 
amide I and amide II bands for the four isomers of (L+D)-h16:0-(e+t)- 
d18:0 are respectively 1645 cm
-1 
and 1545 cm
-1 
(L-e),1645 cm
-1 
and 
1530 cm  1620 cm  1545 cm-1 (D-e), and 1615 cm -1 and 
1545 cm
-1 
(D-t). The amide II overtone at 3070 cm
-1 
was present only 
in the spectra for the e-derivatives. 
The spectra for 0-acyl sphingoids are characterised by sharp peaks 
for v 0-H, v N-H, v C=0, v C-0-C, and v C-0. For example, 1-0-14:0- 
e-d18:1 absorbed at 3320 cm
-1 
plus 3250 cm
-1 
(v 0-H, v N-H), 1720 cm
-1 
(v C=0), 1600 cm  N-H), 1172 cm  C-0-C), 1032 cm  C-0, 
lowered from the usual position of 1100 cm
-1 
by a-unsaturation and 
a-branching), and 963 cm  C-H for the trans-double bond). The 
presence of these compounds in ceramides are easily determined by the 
ester carbonyl stretch. 
(b) Sphingoid-oxazolines  
The IR spectra of isomeric sphingoid-oxazolines (in Nujol) are 
distinguished by the positions of their C=N and 0-H stretching modes, 
and the region between 1300 cm  1000 cm -1 . With reference to 
Figs. 12 and 13 (p.92), of the four possible isomers only 
representatives of the oxazoline (I) gave a value of 1667 cm
-1 
for 
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v C=N (e.g. Figs. 18 and 19). The other isomers (II, III, and IV) gave 
a lower value, 1656 cm
-1 
for v C=N (e.g. Fig. 20 for a representative 
of III), due to the decreased association with the hydroxyl hydrogen. 
Other workers
25
'
149 
have reported v C=N values of 1665 cm
11 
and 
1667 cm
-1 
for representatives of (II); in the former case
25
, 
isomerisation to (I) may have occurred, as was mentioned before (p.91). 
The position of v 0-H varies only slightly for each isomer, 
occurring between 3250 cm1 and 3200 cm -1 for the oxazolines derived 
from d18:0, and 3150 cm
-1 
for the oxazoline (I) derived from d18:1. 
Other workers 25 ' 149 have reported v 0-H values of 3460 cm 1 and 
3333 cm
-1 
for representatives of (II). 
The region between 1300 cm  1000 cm  the spectra of 
representatives of (I) show many sharp peaks, some of which are due 
to the C-0 and C-O-C stretching modes. Oxazolidine ring systems have 
three IR bands between 1200 cm
-1 
and 1100 cm
-1 
characteristic of the 
O-C-N group15() ; frequencies higher than these could indicate a 
contribution from 0-C=N. 
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APPENDIX 1 
SPHINGOLIPIDS FROM THE MILK OF FRIESIAN COWS 
The methods for the isolation of the sphingomyelin and 
glycosylceramides from milk have been described in Chapter 1 (P.16); 
ceramides were isolated from the lipid fraction rich in these by 
preparative TLC. Sphingomyelin and monoglycosylceramides were 
converted to ceramides 58 ' 92 , which were separated by TLC into two 
classes, NFA and HFA derivatives; the former were separated again by 
TLC on plates impregnated with borate into two fractions, one 
containing saturated sphingoids and the other unsaturated sphingoids
71
. 
All the ceramide fractions, and the diglycosylceramides, were 
hydrolysed
98
, and the methyl esters analysed by GLC by the method 
described in Chapter 1 (p.33). The mixture of normal and hydroxy 
methyl esters from the diglycosylceramides were separated by TLC prior 
to analysis. 
The structures of the main glycosphingolipids of Friesian milk 
were shown to be glucosylceramides and lactosylceramides by 
comparison of their IR spectra with those of the glycosphingolipids 
from other milk samples
48,151 , and by TLC on plates impregnated with 
borate
152
. The proportion of hydroxy fatty acids in these compounds 
was higher (6% w/w of the total) in whole Friesian milk than in 
buttermilk power (less than 1%) 153 ; sphinyomyelin contained less 
than 1% (w/w) of hydroxy fatty acids. The fatty acid compositions 
of the sphingolipids are tabulated (Table 1), and the separation of 
the methyl esters derived from NFA sphingomyelins and HFA sphingo- 
myelins are illustrated (Figs. 1 and 2 respectively). The 
principal acids, in decreasing order of importance, of NFA sphingo- 
lipids are 23:0, 24:0, 22:0, and 16:0, and of HFA sphingolipids are 23:0, 
101 
h23:0, h24:0, h22:0 and h16:0. Such results have been observed by 
others for ceramides 103 , sphingomyelin154 ' 155 , glycosy1ceramides 93 ' 153 , 
and gangliosides
156
, all obtained from either buttermilk powder or 
Holstein cow milk. The similarity in the composition of the 
sphingolipids suggests (a) that unsaturated sphingoids are derived 
from saturated sphingoids
157
, and (b) that ceramides may be a common 
precursor in their biosynthesis, although the ceramides may have been 
partly derived from the sphingomyelins by enzymatic hydrolysis". 
Table 1  
Fatty acid composition (weight %) of the major sphingolipids from the milk of Friesian cows 
Fatty acid Ceramide Sphingomyelin 
HFAa 
Glucosyl ceramide Lactosyl 	ceramide 
NFAa NFAb NFAc NFAb NFAc HFAa NFAa HFAa 
12:0 0.5 0.1 trace 0.1 - - - 1.1 trace 
14:0 1.7 0.7 0.4 	, 1.9 1.2 0.3 1.9 5.9 1.4 
15:0 0.1 0.2 0.2 0.2 0.2 0.1 trace 0.4 0.1 
16:0 16.8 14.0 15.8 8.3 9.8 10.8 9.7 16.6 13.5 
16:1 0.1 0.2 0.1 - 0.3 ' 	0.1 - 0.5 - 
17:0 0.5 0.3 0.3 - 0.3 0.2 0.5 0.4 0.8 
18:0 3.6 2.9 2.2 3.9 2.8 1.3 3.8 10.4 4.2 
118:0 4.2 6.3 3.6 - 1.1 1.3 - 4.9 - 
18:1 1.6 0.2 0.2 0.2 - 0.5 0.1 
18:2 0.6 trace 0.1 - - - - - - 
19:0 0.3 0.8 0.4 0.6 0.4 0.2 trace 0.1 - 
20:0 0.6 1.6 1.0 1.6 1.8 0.8 2.3 2.2 1.2 
21:0 0.9 1.4 0.8 1.5 2.1 0.2 1.0 1.2 1.3 
21:1 trace 0.2 trace - 1.9 0.8 - - 
22:0 16.7 17.4 . 18.6 16.5 22.3 23.9 18.9 17.2 16.2 
22:1 0.2 2.0 0.3 - 2.1 1.0 - - - 
Table 1 (continued) 
23:0 23.5 23.4 24.3 32.0 25.9 29.8 34.7 19.5 24.8 
23:1 0.8 2.5 0.6 0.2 2.6 1.3 0.3 0.8 2.9 
24:0 17.7 14.6 19.9 17.9 18.9 21.5 19.0 15.6 23.8 
24:1 4.6 5.9 3.8 7.3 2.8 3.9 2.1 0.8 3.8 
25:0 2.6 3.0 2.1 3.8 1.7 0.9 2.4 1.0 1.5 
25:1 0.9 1.6 . 0.9 1.4 1.9 1.5 1.1 0.3 1.2 
• 26:0 0.5 0.6 0.5 1.3 2.1 1.0 1.3 0.4 1.7 
26:1 0.3 0.4 0.3 1.5 0.3 0.1 0.7 0.2 0.9 
• 27:0 • 0.1 0.4 • 0.2 0.1 0.5 0.2 0.2 0.2 0.1 
27:1 0.2 0.2 0.3 - 0.3 0.1 - 0.1 - 
28:0 0.2 0.8 . 0.1 0.1 0.9 0.3 0.2 0.1 - 
28:1 • 0.1 trace 0.2 - trace - - - 0.1 
Total 
unsaturates 9.5 13.8 7.0 10.6 12.3 8.9 4.3 4.2 8.9 
a) derivatives of total sphingoids. b) derivatives of saturated sphingoids. c) derivatives of unsaturated 
sphingoids. 
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Fig. 1. GLC of the normal methyl esters derived from bovine milk 
sphingomyelin. Operating conditions have been described in Ch. 1 (p.33). 
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Fig. 2. 	GLC of the 2-trimethylsiloxy methyl esters derived from bovine milk 
sphingomyelin. Operating conditions have been described in Ch. 1 (133). 
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APPENDIX 2  
SERUM LIPIDS IN WORKERS EXPOSED TO LEAD 
Blood sera from 68 male adults from the Electrolytic Zinc 
Company (Hobart, Tas.) were analysed for cholesterol, free ceramide, 
and monoglyceride, by the spectrodensitometric method described 
in Chapter 1 (p. 29). The results are compared to those of 
normal adults not exposed to such industrial conditions (Table 1), 
and those of other normal surveys
79
. The mean values for free 
cholesterol and total cholesterol are similar to the normal values, 
but ceramides and monoglycerides are present in higher concentration 
• in workers exposed to lead than in normals. These findings require 
further investigations which are outside the scope of this project; 
they appear in this thesis as an example of practical application of 
analytical methods treated in Chapter 1. • 
Table 1  
Serum lipids of industrial employees exposed to heavy metals, in particular, lead 
Number NFA Ceramides (mg %) Monoglycerides (mg %) Free 
Cholesterol (mg %) 
Total 
Cholesterol (mg %) 
Total/Free 
Cholesterol 
1 1.8 23 204 
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8 3.0 34 177 
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10 2.1 48 202 
11 1.8 23 148 
12 1.8 35 200 
13 2.1 44 226 
14 1 20 192 
15 1.8 31 242 
16 1 44 277 
17 1 27 200 
Table 1 (continued) 
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20 2.1 7 39 296 
21 6.1 7 97 276 
22 4.1 7 102 260 
23 5.8 -. 	2 109 . 	296 
24 4.5 2 57 215 
25 5.8 7 97 296 
26 3.8 9 57 222 
27 2.1 7 48 215 
28 3.0 9 78 258 
29 1.8 9 66 232 	, 
30 4.1 18 92 234 
31 2.1 22 88 221 
32 4.1 18 97 248 
33 3.5 9 97 331 
34 3.8 30 97 364 
35 3.8 28 92 298 
36 3.5 18 74 250 
37 5.8 22 82 257 
38 6.1 35 114 298 
39 3.8 10 66 212 
Table 1 (continued) 
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41 26 70 . 	274 
42 25 43 200 
43 25 78 267 
44 30 97 309 
45 .. 	30 92 252 
46 18 66 220 
47 22 74 236 
48 28 78 261 
49 38 64 210 
50 
CFI . 	15 103 290 
51 30 88 268 
52 25 78 192 
53 18 60 186 
54 40 92 242 
55 18 57 212 
56 30 92 304 
57 . 	18 55 208 
58 40 103 282 
59 25 66 193 
60 28 64 260 
61 38 70 268 
Table 1 (continued) 
62 1 8 50 202 4.0 
63 1.8 18 48 186 3.9 
64 3.0 11 87 209 2.4 
65 1 9 46 160 3.5 
66 1.8 30 66 202 3.1 
67 1 9 55 254 5.0 
68 1 7 66 212 3.2 
Mean ± ISO 3.6 ± 1.8 15.8 ± 10.5 67.3 ± 24.2 241 ± 42.2 3.6 ± 1.7 
Control 2.7 7 63 217 ' 3.4 
APPENDIX 3  
LIPOAMINO ACIDS 
Since amino acids were found in lipid extracts in the course 
of this work, compounds soluble in typical solvents for lipids, and 
in which a single amino acid or peptide was covalently linked either 
through the carboxyl or amino group to a neutral lipid moiety, were 
studied under this heading. Proteolipids and lipopeptides158 , and 
aminoacylphosphatides of the kind found in bacteria 159 , and 
phosphatidyl serine, will be excluded. 
1. Review  
Investigations of the lipids of tissues and microorganisms 
have not shown unequivocally the presence of lipoamino acids in all 
cases. The formation of lipid-amino acid complexes has, however, 
been reporced in cellular preparations, such as hen oviduct mince'
60,161 
 
In general, the complex has bean demonstrated after addition of 
• radioactive amino acid to the cell preparation, in a medium of 
supporting metabolism, by the measurement of radioactivity in a crude 
or purified fraction extracted with lipid solvents, and the subsequent 
recovery of the unchanged amino acid after hydrolysis. It was found 
that the complexes could be separated into discrete fractions by 
countercurrent distribution and column chromatography. Furthermore, 
the non-polar lipid fraction eluted from silicic acid with benzene 
contained virtually no radioactivity; this argues against the 
participitation of neutral lipids in the complexes; it was suggested 
that neutral lipids containing amino acids might well behave like 
polar lipids 160 . 
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The constituent lipids of whole human blood have been examined 
by chromatography on columns of silicic acid
162
. All lipid fractions, 
with the exception of the least polar fractions (cholesterol esters 
and triglycerides) liberated amino acids on hydrolysis. In a later 
paper by the same author, it was concluded that some lipid-amino acid 
complexes are artefacts formed in vitro from endogenous amino acids, 
but that others do exist in vivo
163
. 
The nature of the bonding between the amino acids and the lipids 
has been investigated
164
. To determine whether the carboxyl groups 
of the amino acids were covalently linked to the lipids by ester bonds, 
the reaction of various lipid-amino acid complexes with hydroxylamine 
were studied; the presence of both ester and possibly amide bonding 
was established. The presence of N-acylamino acids in skin has been 
suggested, but not proven
165
. 
2. Evidence for the existence of lipoamino acids  
Proof for the existence of natural lipoamino acids could not be 
found by the use of TLC alone, although this technique did provide 
some evidence. For example, plates'overloaded with natural lipids 
and then developed to separate the neutral ones gave some very faint 
positive ninhydrin reactions around cholesterol. The degree of 
reaction increased when the plates were sprayed with hydrochloric acid 
after development, heated for 30 minutes at 120 0 , and then sprayed 
with ninhydrin. 
Stronger evidence was found by the use of GLC. The neutral 
lipid fractions (cholesterol esters, triglycerides, and cholesterol) 
and fatty acids of blood plasma (heart disease cases) were isolated 
by TLC, and treated with 6N hydrochloric acid overnight at 110°. The 
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lipid residues were removed by extraction with chloroform, and the 
aqueous phase filtered and evaporated to dryness. TLC was found 
inadequate for identifying the amino acids in the residue
166
, and GLC, 
especially the method of Gehrke et. al.
87
, was routinely used (p.37). 
The compositions of the lipid-bound amino acids were compared with 
those of the free amino acids of the plasma samples. There seemed to 
be no apparent order in the amino acid patterns of any of the lipid 
extracts, but the relative concentrations of some lipid-bound amino 
• acids differed greatly from those of the free amino acids (Table 1). 
This is an indication that the amino acids are not present in lipids 
. simply as artefacts, although the lipids may act as better solvents for 
the higher molecular weight species. 
Table 1  
Relative ratios of some free and lipid-bound amino acids in plasma. 
Lipid class Amino acid ratios 
Ly s/Try Tyr/His Gly + Ala leu + ileu 
free amino acids 1 - 1 1 
cholesterol esters 0.66 1.45 10.98 
cholesterol 0.26 0.88 12.72 
triglyceri 4 es 0.51 0.42 1.56 
fatty acids - 0.23 3.64 
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3. The synthesis of lipoamino acids  
(a) Cholestanol and cholesterol esters of amino acids  
The preparation of cholestanol esters of neutral, non-hydroxy 
amino acids was carried out essentially by a method described by 
others, that of direct fusion of cholestanol with the amino acid in 
the presence of dry hydrogen chloride
167
. The product was dissolved 
in chloroform, and ammonia added to liberate the free ester from its 
salt. The ammonium chloride was washed out with water, the solvent 
removed, and the ester recrystallized from ethanol. Some of the 
compounds prepared are tabulated (Table 2). 
Cholesterol esters of amino acids could not be synthesised by 
direct fusion, and the following method was used. Cholesterol (1 mmole), 
N-phthaloyl DL-alanyl chloride
168,169 
(1 mole) and triethylamine (1.45 
mole) were fused at 150 0  under nitrogen to give a high yield (70-80%) of 
cholesterol N-phthaloyl DL-alaninate (no product was formed when the 
reaction was carried out in pyridine). Recrystallization from ethanol 
afforded 300 mg of white crystals, m.p. 137-138°, and which gave a single 
spot (Rf 0.7) on a TLC plate developed with chloroform-methanol (98:2). 
The phthaloyl derivative (200 mg) was refluxed for one hour with 
hydrazine (0.3 mole) in ethanol (30 ml), without appreciably affecting 
the ester bond. The phthaloyl hydrazide was removed, and the crude 
cholesterol DL-alaninate (120 mg) purified by TLC (developing solvent, 
chloroform-methanol (93:7)). The derivative was found difficult to 
obtain free of contaminating cholesterol and starting material, either 
by TLC, column chromatography, or crystallization. However, the 
• hydrochloride salt (m.p. 232° (dec.)) could be isolated after treating 
an ethanolic solution of the free amine with 6 N hydrochloric acid. 
This compound was stable under normal laboratory conditions, but the 
Table 2  
Cholestanol and cholesterol esters of amino acids a 
No. Compound Name 
' M.p.° Yield % R
f 
value
b 
Formulae 
C% 
Found 
(Calcd.) 
H% 
Found 
(Calcd.) 
N% 
Found 
(Calcd. 
cholestanol glycinate HC1 c 245-6 48 0.45 
(dec.) 
cholestanol glycinate c 178-180 47 0.45 
3 cholestanol alaninate HC1 c 'd 238 66 0.62 C30H 5402NC1 71.6 11.0 2.8 
(dec.) (72.6) (11.0) (2.8) 
4 cholestanol alaninatec ' e 120 68 0.62 C30H 530 2N 78.2 11.6 3.0 (78.4) (11.6) (3.0) 
5 cholesterol alaninate HCl f 138 30 0.62 C30H 5202 NC1 72.6 10.6 2.7 (73.6) (10.8) (2.8) 
6 cholestanol prolinate HC1 224-7 65 0.49 C 31 H 570 2NC1 72.7 10.7 2.5 
(dec.) (73.6) (10.8) (2.7) 
7 cholestanol prolinate 133-5 64 0.49 C 31 H 560 2N 79.2 11.4 2.9 (79.1) (11.4) (2.9) 
8 cholestanol phenylalaninate HC1 226-8 42 0.74 C35H 580 2NC1 74.8 10.1 2.4 
(dec.) (75.5) (10.2) (2.5) 
9 cholestanol glycylleucinate 98-100 32 0.35 C35 H 61 03 N 2 75.9 10.9 4.5 (75.4) (11.0) (5.0) 
a) New compounds are underlined. 
cholesterol or cholestanol, 0.68. 
e) No analytical data gi.;en 167 . 
b) Developing solvent, CHC13-CC14-CH30H-H20 (50:50:10:0.5); Rf value for 
c) Higher yields obtained here than rePorted 167 . d) Reported M.p. 258° ( dec.) 16 
f) Analysis for Cl, Found 7.4; Calcd. 7.2. 
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Table 3  
N-acylamino acids and N-acylpeptides, and derivatives related to glyceryl esters of amino acids a 
No. Compound Name M.p.° Yield % R value
b 
f 
Formulae 
C% 
Found 
(Calcd.) 
H% 
Found 
(Calcd.) 
N% 
Found 
(Calcd.) 
1 
2 
3 
5 
6 
N-stearoyl DL-alaninec 
N-stearoyl DL-threonine 
N-stearoyl DL-glycylleucine
d 
1-(N-phthaloyl DL-alany1)- 
2,3-propenoate 
1-(N-phthaloyl DL-alany1)- 
2,3-epoxypropane 
1-(N-phthaloyl DL-alany1)- 
propane-2,3-diole 
109-110 
82-6 
103-5 
38.5 
61-3 
- 
84 
79 
65 
89 
73 
45 
0.76 
0.69 
0.78 C26H5004N 2 
C14 H1304N 
C14H 130 5N 
C14 H150 6N 
67.2 
(67.7) 
64.8 
(64.9) 
61.4 
(61.1) 
56.4 
(57.3) 
11.1 
(11.1) 
5.1 
((5.1) 
5.1 
(4.8) 
5.6 
(5.2) 
6.3 
(6.2) 
5.6 
(5.4) 
5.3 
(5.1) 
4.7 
(4.8) 
a) All compounds, with the exception of No. 1, are new. b) Developing solvent,CHC13CH3OH-H20 (65:25:4); the N-acyl 
derivatives move with cerebrosides. c) This compound has the same properties as the active one reported, 1.e. 
N-stearoyl L-alanine170 . d) The IR spectrum shows absorption at 3335 cm -1 and 3310 cm -I (v N-H), 1735 cm - I (v C=0), 
1650 cm-1 and 1618 cm -1 (amide I), 1544 cm' and 1513 cm' (amide II), and 1263 cm - I and 1245 cm' (amide III). 
e) This compound could not be induced to crystallize. 
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free amine deteriorated over several weeks in cold chloroform. 
(b) N-acylamino acids  
N-acylamino acids and N-acylpeptides were synthesised by the 
method of Suyama et al.
170
, and purified by recrystallization from 
chloroform or hexane-chloroform mixtures. The IR spectra of the 
compounds tested have a band at 3310 cm
-1 
(v N-H), which would probably 
be characteristic of all N-acylamino acids except the basic ones. 
The positions of the bands due to the ester and amide groups vary. 
Some of the compounds tested have been analysed (Table 3, Nos. 1 to 3). 
(c) Glyceryl esters of amino acids  
The preparation of glyceryl esters of neutral, non-hydroxy amino 
acids was not possible by direct fusion methods. The reaction 
between a-monostearin and alanine in the presence of dry hydrogen 
chloride produced mainly distearin and glycerol. A reaction scheme 
similar to that for the production of cholesterol esters of amino 
acids was attempted, but the final step of removing the phthaloyl . 
group with hydrazine, either hot or cold, resulted in the destruction 
of the ester bond. However, some new compounds were prepared (Table 
3, Nos. 4 to 6) which may be useful for further work of this nature. 
( 1) 1-(N-phthaloyl DL-alany1)-2,3-propenoate  
N-phthaloyl DL-alanyl chloride (10.6 g), allyl alcohol (35 ml, 
a 0.25 M excess), and pyridine (30 ml) were refluxed under nitrogen 
for 1 hour, cooled, and the solution poured into an ice-cold saturated 
sodium bicarbonate solution (100 ml) with vigorous stirring. A light 
yellow oil settled out, which was extracted into ether (2 x 100 ml), 
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washed with water and 10% sodium chloride solution, and dried over 
anhydrous sodium sulphate. The ether was removed under reduced 
pressure, and the residual oil dissolved in a minimum volume of hot 
petroleum ether (60-80). On cooling, a colourless oil reprecipitated, 
which was crystallized by shaking vigorously in an ice-salt bath. 
The white product obtained was chromatographically pure, and showed the _ 
desired spectral characteristics. 
(ii)1-(N-phthaloyl DL-alany1)-propane-2,3-diol  
Hydroxylation of the double bond in the ester (i) was carried out 
in hot hydrogen peroxide-acetic acid, a method which has been used 
successfully both with and without a catalyst for the hydroxylation of 
allyl alcohol
171 
 . The allyl ester (4 mole) was dissolved in glacial 
acetic acid (4 ml), hydrogen peroxide (8 mole) added and the solution 
heated on a water bath at 80° for two days. Practically all of the 
allyl ester had reacted after this time, as judged by TLC, and two 
products of Rf values 0.30 and 0.60 (developing solvent, CHC1 3 -CH3OH 
(92:8)) were separated. Both compounds were colourless viscous liquids 
which could not be induced to crystallize. The product corresponding 
•to R
f 
0.30 was shown spectrally to be 1-(N-phthaloyl DL-alany1)- 
glycerol (yield 0.53 g) and it gave a positive periodate-Schiff's 
reaction on the plate indicating the 1,2-diol group
76
. The product 
corresponding to R f 0.60 (yield 0.4 g) gave a negative periodate-
Schiff's test, and was determined to be an acetate (formed probably 
during the reaction via the ion, R-C-0-CH 2-CH-CH 2 ) by analysis of its 
\0/ 
•+ 
spectra, e.g. a methyl singlet at 7.9 T in the NMR spectrum and a 
sharp OH stretch in the IR spectrum (3470 cm-1). 
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A second method for hydroxylation was carried out on a small 
scale using osmium tetroxide 172 ; in this case the acetate was not 
formed, and TLC indicated the major reaction product the same as 
above. 
(iii) 1-(N-phthaloyl DL-alany1)-2,3-epoxypropane  
Epoxidation of the double bond in the ester (i) was carried out 
with m-chloroperbenzoic acid
173
. The allyl ester (0.01 mole) and 
metachloroperbenzoic acid (2.5 g of 83%) in dichloromethane (30 ml) 
were stirred overnight at room temperature (21°). Titration of an 
aliquot with standard sodium thiosulphate solution indicated 35% 
reaction. A little catalyst was now added (18 pl of trifluoroacetic 
acid), the temperature raised to 27°, and the reaction allowed to 
continue for three days. After this time 70-80% reaction had occurred. 
The excess peracid was destroyed with sodium sulphite (0.76 g) and the 
epoxide freed from m-chlorobenzoic acid by washing with 5% sodium 
bicarbonate solution, followed by 10% sodium chloride solution and 
finally water. The solvent was evaporated, and the residual oil 
crystallized from petroleum ether (60-80)-ethyl ether (9:1) at -10°. . 
It showed one TLC spot only, gave a positive periodate-Schiff's test, 
and its spectra indicated the epoxide. 
(d) N-aminoacyl sphingoids  
N-phthaloyl DL-alanyl chloride (1 mmole), DL(e+t)-d18:0 (1 mmole) 
and triethylamine (160 pl) in dimethylformamide (2 ml) were allowed to 
stand overnight at room temperature. Ether (200 ml) Was added, the 
mixture washed with water, and the solvent removed under reduced 
pressure. N-phthaloyl DL-alanyl-DL(e+t)-d18:0, m.p. 98-104 ° , was 
isolated by preparative TLC (developing solvent, chloroform-methanol 
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(9:1)) in 80% yield. The phthaloyl group was removed by treatment 
with hydrazine (0.8 mmole) in alcohol (3 ml) at 40 0  for two days. 
The diastereoisomeric mixtures, L-alanyl-DL(e+t)-d18:0, and D-alanyl-
DL(e+t)-d18:0, were isolated from the reaction mixture by TLC 
(developing solvent, chloroform-methanol (3:1) ; yield, 28% of each); 
the Rf 
values were 0.35 and 0.27 respectively. Their structures 
were confirmed by TLC comparison with the products derived from either 
L- or D-alanine, and by IR spectroscopy (3280 cm -1 , 3080 cm-1 , 1642 cm-1 , 
-1 -1 
1255 cm, 1075 cm, and vibrations due to C-H for both compounds; 
the L- and D-isomers were distinguished by adsorption at 1525 cm 
-1 
1550 cm respectively). On TLC plates impregnated with borate, 
compounds containing e-d18:0 were separated from those containing 
t-d18:0. 
The compound, DL-alanyl-De-d18:1, prepared by the above method 
on a smaller scale, gave similar chromatographic and spectral 
properties as described for the saturated analogues. 
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